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1 Nanomaterials 
1.1 Definition 
Nanomaterials (NMs) are defined as materials having at least one dimension in the 
nanoscale range and, likewise, nanoparticles (NPs) consist of materials with all three 
dimensions in the nanoscale range (Buzea et al., 2007). According to the European 
Commission, NMs are constituted by material with 50 % or more of the particles in the 
number size distribution having one or more external dimensions in the range of 1-100 
nm (European Commission, 2011). However, in nanomedicine the useful dimensional 
range is reported to fall within 5-250 nm (Garnett and Kallinteri, 2006). 
1.2 Sources 
NMs derive from natural or anthropogenic sources (Christian et al., 2008; Dhawan and 
Sharma, 2010). They are produced in many natural processes, including photochemical 
reactions, volcanic eruptions, forest fires and simple erosion. These natural phenomena 
are estimated to generate 90% of nanoparticulate matter in air, while the remaining 10% 
ensues from human activity (Buzea et al., 2007). Anthropogenic NMs can be divided into 
two categories: incidental and engineered/manufactured (Dhawan and Sharma, 2010). 
Incidental NMs, which are produced unintentionally, can derive from combustion and 
food cooking, chemical manufacturing, welding, combustion in vehicle and airplane 
engines, combustion of coal and fuel oil for power generation (Buzea et al., 2007). 
Engineered NMs, according to their physico-chemical properties, are applicable in 
many fields and already present in market (Buzea et al., 2007). This increasing 
development of nanotechnology (i.e. the design, synthesis, and application of 
engineered NMs) causes accidental or intended release of new materials in the 
environment (Christian et al., 2008). 
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1.3 Engineered NMs 
Engineered NMs can be categorized by their composition into organic, metallic, carbon-
based, silicon-based and composite NMs (Christian et al., 2008; Abhilash, 2010; Stone 
et al., 2010).  
Organic NMs include polymers, dendrymers and liposome NPs, and find many 
applications in nanomedicine, such as drug delivery (Abhilash, 2010).  
Metal-based NMs, according to their physico-chemical properties, have widespread 
medical and industrial applications, as summarized in Table 1 (Schrand et al., 2010).  
TABLE 1. Examples of applications of metal-based NMs (from Schrand et al., 2010). 
Nanoparticle Application 
Silver 
(Ag) 
Antimicrobial, photography, batteries, electrical 
Aluminum 
(Al) 
Fuel additive/propellant, explosive, wear 
resistant coating additive 
Gold 
(Au) 
Cellular imaging, photodynamic therapy 
Cerium 
(CeO2) 
Polishing an computer chip manufacturing, fuel 
additive to decrease emissions 
Copper 
(Cu) 
Antimicrobial, nanocomposite coating, catalyst, 
lubricants, inks, filler materials for enhanced 
conductivity and wear resistance 
Iron 
(Fe, Fe3O4, Fe2O3) 
Magnetic imaging, environmental remediation 
Manganese 
(Mn) 
Catalyst, batteries 
Nickel 
(Ni) 
Conduction, catalyst, battery manufacturing, 
printing inks 
Titanium dioxide 
(TiO2) 
Photocatalyst, antibacterial coating, 
sterilization, paint, cosmetics, sunscreens 
Zinc 
(Zn, ZnO) 
Skin protectant, sunscreens 
INTRODUCTION 
8 
 
Fullerenes and carbon nanotubes are the main carbon-based NMs (Christian et al., 2008; 
Abhilash, 2010). The first are potentially useful in optics, superconductors and for drug 
delivery (Oberdörster et al., 2007); the latter show important applications in energy 
storage and as nanoprobes and sensors in biological and chemical investigations 
(Ajayan and Zhou, 2001).  
Silicon-based NMs, such as SiO2 NPs, have great importance in industrial (such as the 
fabrication of electric and thermal insulators) and medical applications (as drug carrier, 
catalyst support and gene delivery) (Abhilash, 2010; Schrand et al., 2010).  
Composite NMs are a heterogeneous group comprising multi-component NMs (Stone 
et al., 2010). Among them, quantum dots are fluorescent semiconductor nanocrystal 
with many biological applications, such as fluorescence labeling both in cellular and in 
vivo imaging (Michalet et al., 2005). 
1.4 Properties 
The particular interest in NMs is related to the peculiar physico-chemical properties, 
which differ from their bulk counterpart (Nel et al., 2006). The small size confers to these 
materials an exceptionally high surface area to volume ratio: as the particle size 
decreases, its surface area increases (Fig. 1) allowing a greater proportion of its atoms or 
molecules to be displayed on the surface rather than the interior of the material (Nel et 
al., 2006; Christian et al., 2008). 
 
FIGURE 1. Inverse relationship between particle size and number of surface 
expressed molecules (from Nel et al., 2006). 
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The increased surface-to-volume ratio is responsible for enhanced NM reactivity 
(Christian et al., 2008; Jones and Grainger, 2009) and their use in many application 
fields as catalysts and contrast agents. NM surfaces can also be modified with a wide 
range of molecules for biomedical purposes. For example, NPs can link specific markers 
and drugs for diagnostic and drug delivery (Jain, 2008; Dothager and Piwnica-Worms, 
2011). Since NMs can bind and adsorb molecules, they are often stabilized with a range 
of small molecules (e.g. citrate), surfactants (e.g. sodium dodecyl sulphate, SDS) or 
polymers (e.g. polyvinylpyrrolidone, PVP, and polyethylene glycol, PEG) that are used 
for stabilizing them or to prevent opsonization (i.e. the binding of molecules, such as 
antibody, on the surface of NMs to enhance phagocytosis) in biomedical applications 
(Christian et al., 2008; Pachón and Rothenberg, 2008). 
Metal-based NPs, such as Pb, In, Hg, Sn, Cd, Ag and Au, exhibit size-dependent light 
absorption through excitation of the metal’s plasma band electrons by incident photons 
and scattering of incident beam (Jones and Grainger, 2009). The plasmonic absorbance 
peak reflects NP size since decreases in intensity and red shifts are related to increase in 
NP diameter (Fig. 2). 
 
FIGURE 2. Uv-vis absorption spectra of 9, 22, 48 and 99 nm AuNP in water. All 
spectra are normalized at their maximum absorbance maxima (modified from 
Link and El-Sayed, 1999). 
In addition, engineered NMs can be synthesized with different shape (e.g., spherical, 
rope-shaped, wire-shaped, rod-shaped etc.). Shape is important in determining the 
interaction with cells and in the development of NM-based targeting strategies for 
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therapeutic applications (Yang et al., 2009; Fadeel and Garcia-Bennett, 2010; Sharifi et 
al., 2012). 
2 Nanotoxicology 
The increased use of NMs and their consequent release in the environment give rise to 
many concerns regarding their fate in biological systems and their potential effects on 
human health and ecosystems. For these reasons, nanotoxicology was proposed as a 
branch of toxicology to address the potential toxic impacts of NMs on biological and 
ecological systems (Donaldson et al., 2004).The peculiar physico-chemical properties of 
NMs differentiating them from bulk materials can influence their interaction with 
biological systems and pose challenges to classical toxicological assays (Dhawan and 
Sharma, 2010). Nanotoxicological studies require a much more extensive physico-
chemical characterization than other chemical compounds, though the lack of 
standardized methodologies makes difficult to compare the safety/toxicity assessments 
from different research groups (Nel et al., 2006; Buzea et al., 2007; Dhawan and Sharma, 
2010). 
2.1 Physico-chemical properties affecting NM toxicity 
The physico-chemical properties affecting NM toxicity are mainly attributable to their 
small size, surface chemistry, dissolution, shape and chemical composition (Nel et al., 
2006). 
2.1.1 Size 
Size is a critical parameter in determining NM properties and toxicological impacts. 
Many studies report a relationship between toxicity and size in both in vitro and in vivo 
systems. In particular, these studies showed higher toxic effects for small NPs than 
larger ones (Liu et al., 2010; Gliga et al., 2014; Ivask et al., 2014; Zhang et al., 2014). The 
negative correlation between size and toxicity is mediated by several factors, such as 
NM ability to cross biological barriers and cellular membranes (Buzea et al., 2007; 
Freese et al., 2012; Zhang et al., 2014). Given the importance of size in influencing 
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possible toxic effects of NMs, their stability in biological media needs to be evaluated. 
Indeed, NMs tend to aggregate or agglomerate in gas or liquid suspensions (Oberdörster 
et al., 2007). Agglomeration involves the adhesion of particles to each other, mainly due 
to Van der Waal’s forces, while aggregation involves a fusion of particles [Fig. 3; (Stone 
et al., 2009; Dhawan and Sharma, 2010)]. This means that agglomerates might be easily 
separated by dispersants or small amount of energy, while dispersion of aggregates is 
unlikely (Stone et al., 2009). 
 
FIGURE 3. Agglomeration and aggregation of nanoparticles. Aggregates can 
additionally agglomerate (modified from Oberdöster et al., 2007).  
Agglomeration depends on concentration, surface chemistry and suspension medium 
and, in the agglomeration state, NMs may behave as larger particles, depending on the 
size of agglomerates (Buzea et al., 2007; Oberdörster et al., 2007). 
2.1.2  Surface chemistry 
NM surface is responsible for the interactions with biological systems (Nel et al., 2009). 
NM characteristics determining surface properties are chemical composition and 
surface functionalization (Nel et al., 2009). Uncoated NMs, especially metal ones 
(MeNMs), undergo surface modifications in biological environments (Auffan et al., 
2009; Benetti et al., 2014). The most common modifications are surface passivation, 
changes in surface charge, protein absorption, interactions with small molecules and 
ion release (Fig. 4). 
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FIGURE 4. Chemical modifications of metal NP (MeNP) in biological 
environment: oxidative dissolution (Men+), surface passivation (MexOy), 
changes in surface charge, protein adsorption and interactions with small 
molecules. The interaction of released ions with biological components can 
leads to soluble ([MexLy]aq) or insoluble ([MexLy]s) complexes. These latter may 
lead to the formation of secondary MeNP (from Benetti et al., 2014). 
NM surfaces can be functionalized during their synthesis (Christian et al., 2008; Pachón 
and Rothenberg, 2008). All these modifications can drastically change NM physico-
chemical properties, such as agglomeration, magnetic, electric and optical properties, 
dissolution, chemical reactivity and toxicity (Nel et al., 2006; Buzea et al., 2007). For 
example, cationic NMs result to be more toxic than negative-charged ones as they have 
major affinity to the negative phospholipid head groups or protein domains on cell 
membranes (Sharifi et al., 2012).  
2.1.3 Dissolution 
NM toxicity can be mediated by ion release in both biological media and intracellular 
compartments (Misra et al., 2012; Sabbioni et al., 2014). Understanding the role of ion 
release in NM toxicity is crucial to disclose molecular mechanisms affecting the impact 
of NM on biological systems. NP dissolution depends on several physico-chemical 
parameters as shown in Figure 5. 
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FIGURE 5. Physico-chemical factors affecting dissolution of NPs (from Misra et 
al., 2012) 
Size affects dissolution as showed by the higher ion release from small NPs compared to 
the larger ones (Zhang et al., 2010; Zhang et al., 2011; Xiu et al., 2012; Wang et al., 2014). 
Dissolution, indeed, follows the Gibb–Thomson effect, which predicts that MeNP with 
smaller radius of curvature are energetically unfavorable and subject to dissolution, 
having a higher equilibrium solubility than macroparticles (Batley and McLaughlin, 
2007). Moreover, size affects dissolution by influencing the specific surface area and the 
number of NMs for the same mass/volume dose (Gliga et al., 2014; Wang et al., 2014). As 
dissolution involves NM surface, the presence of coatings can alter ion release (Kirchner 
et al., 2005; Kittler et al., 2010; Zook et al., 2011; Gliga et al., 2014; Wang et al., 2014). 
Coated NMs are generally more stable in suspension than uncoated ones that 
agglomerate easily causing a slower dissolution kinetic due to the reduction of NP 
exposed surface area (Gliga et al., 2014). Furthermore, dissolution can be also influenced 
by the nature of coatings, for example PVP-stabilized AgNPs show a higher degree of 
dissolution than citrate-coated ones (Kittler et al., 2010; Zook et al., 2011; Wang et al., 
2014). In addition to NM physico-chemical properties, experimental conditions – time, 
temperature, pH, NM concentration and medium composition – influence ion release 
(Kittler et al., 2010). Increase in temperature and acidic pH lead to an increased 
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dissolution degree (Kittler et al., 2010; Studer et al., 2010; Zhang et al., 2010). NM 
concentration has an effect on dissolution kinetics (Zhang et al., 2011; Zook et al., 2011). 
In particular, dissolution rate is positively related to concentration, whereas the 
possible agglomeration process could reduce initial dissolution kinetic (Zhang et al., 
2011; Zook et al., 2011). Again, biological media have an important role in dissolution 
kinetics due to NM modifications (Benetti et al., 2014). For example, fetal bovine serum 
in cell culture media prevents agglomeration of AgNPs and affects dissolution (Park et 
al., 2010). Very few studies have focused on environmental transformations of NMs. 
Regarding AgNPs, the most common modification is the formation of a silver sulfide 
corrosion layer that is related to surface passivation and a reduction in dissolution 
(Levard et al., 2011).  
Until now, it was analyzed ion release occurring in environmental and biological 
solutions. Actually, NMs can enter into cells as particle and then dissolve (Benetti et al., 
2014; Ortega et al., 2014; Sabbioni et al., 2014). This mechanism, named Trojan Horse, is 
reported to be an important process leading to NM toxicity when extracellular 
dissolution cannot fully explain observed toxicity (Park et al., 2010; Studer et al., 2010; 
Cronholm et al., 2013; Novak et al., 2013; Ortega et al., 2014).  
2.1.4 Shape 
Particle shape is an additional key factor that determines the toxicity of NMs (Sharifi et 
al., 2012). Shape influences cellular uptake, organ clearance, agglomeration and 
aggregation, and ion release (Buzea et al., 2007). Endocytosis of NPs is easier and faster 
compared to rod-shaped or fiber-like NPs (Sharifi et al., 2012). Moreover, long fiber-like 
NMs appear to be not effectively cleared from respiratory tract due to the inability of 
macrophages to phagocytize them, so leading to accumulation and potential chronic 
toxic effects (Buzea et al., 2007). 
2.1.5 Chemical composition 
Although size, surface area and shape are important parameters in conferring NM 
toxicity, chemistry composition has an important role in inducing oxidative stress and 
cellular machinery alterations (Sharifi et al., 2012). Chemical composition appears to be 
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relevant when comparing different NMs with similar physical properties (Granchi et 
al., 1998; Yang et al., 2009; Cho et al., 2012). 
2.2 Assessment of NM toxicity 
Due to the importance of NM in many application fields, it is very important to test their 
biological effects. However, the lacking of standard protocols in nanotoxicology makes 
difficult to compare studies from different laboratories and disclose the real impact on 
the environment and human health (Dhawan and Sharma, 2010)  
2.2.1 NM characterization 
To find a correlation between biological effects and NM properties, a comprehensive 
physico-chemical characterization is needed (Dhawan and Sharma, 2010). The physico-
chemical properties commonly evaluated in nanotoxicology field are: size, shape, 
aggregation or agglomeration states, surface area and dissolution. As reported in Table 
2, different methodological approaches can be used for determining these properties 
(Dhawan and Sharma, 2010; Fadeel and Garcia-Bennett, 2010; Love et al., 2012).  
TABLE 2. Nanoparticle properties and common characterization methods. 
Physico-chemical 
properties 
Characterization methods a 
Size TEM, SEM, AFM, DLS, UV-vis (for plasmonic NMs) 
Shape TEM, AFM 
Agglomeration or 
aggregation state 
DLS, UV-vis (for plasmonic NMs) 
Surface area BET 
Dissolution Ultracentrifugation or ultrafiltration coupled with 
ICP-MS and ion-selective electrode potentiometry 
a: Acronyms: TEM, transmission electron microscopy; AFM, atomic force 
microscopy; DLS, dynamic light scattering;UV-vis, UV-visible spectroscopy; 
BET, nitrogen adsorption/desorption isotherm; ICP-MS, inductively coupled 
plasma mass spectrometry 
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Notably, different methods could provide different information, and sometimes a full 
physico-chemical characterization is hampered by the intrinsic properties of NMs. For 
example, TEM analysis provide information about primary size distribution of NMs 
but, in aggregate samples it is not always possible to recognize particle boundaries 
(Dhawan and Sharma, 2010; Tomaszewska et al., 2013). Aggregation can also influence 
DLS analysis in particular for possible sedimentation of aggregates (Teeguarden et al., 
2007). Indeed, DLS provides information about the hydrodynamic radius and 
aggregation of NMs dispersed in solutions in relation to their Brownian motion and, 
consequently, is strongly affected by sedimentation (Dhawan and Sharma, 2010). 
Furthermore, it is not suitable to study polydisperse NMs (Dhawan and Sharma, 2010; 
Tomaszewska et al., 2013). BET technique to study surface area is deeply affected by 
aggregation as it calculates specific surface area accessible to gases (Dhawan and 
Sharma, 2010). Finally, different techniques to study dissolution can lead to different 
information. Ultracentrifugation could overestimate ion release because of the presence 
of NMs in supernatant, while ultrafiltration measures only free ions or ions bound to 
small molecules able to pass through the pores, retaining protein-bounded ions. Ion-
selective electrode potentiometry is interfered by complex matrices such as biological 
media (Bregoli et al., 2013). 
2.2.2 In vitro models 
Nanotoxicology, as well as traditional toxicology, can study the effects of NMs using 
both in vitro and in vivo systems. The in vitro systems have obvious advantages, 
including the reduction of animal testing, the speed of results and the relatively lower 
cost compared to in vivo studies (Stone et al., 2009; Hartung and Sabbioni, 2011). The 
ethical considerations about animal testing is taken in particular consideration as NM 
properties can be easily manipulated generating “new” material to be tested. For 
evaluating NM biocompatibility, in vitro methods are therefore considered useful in 
nanotoxicology research (Sharifi et al., 2012). In vitro testing also permits to change 
physico-chemical parameters in order to investigate molecular mechanisms underlying 
NM toxicity (Stone et al., 2009). The main disadvantage is that in vitro systems are not 
able to fully replicate the complex physiological interactions occurring in organisms 
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(Stone et al., 2009). In vitro models can be represented by (i) primary cells, deriving from 
tissue explants or disaggregate tissues, usually considered the closest models for organs 
and (ii) cell lines, often derived from transformed or transfected cells which have lost 
basic proliferation control mechanisms. Cell lines are extensively used in 
nanotoxicology as they are easy to manage and present low batch-to-batch variability 
(Bregoli et al., 2013). Usually, in vitro models are chosen to reflect a critical component 
of the exposure route (Love et al., 2012; Bregoli et al., 2013). There are four common 
exposure routes to NMs: ingestion, dermal contact, inhalation and injection (Sellers et 
al., 2010; Love et al., 2012). For each exposure route, different in vitro cell lines exist and 
some example are reported in Table 3. Systemic exposure to NMs can be studied using 
in vitro cell models mimicking liver and kidney (Bregoli et al., 2013). 
TABLE 3. Cell lines used in nanotoxicology research in relation to NP exposure. 
Exposure route Cell lines References 
Ingestion Caco-2 (undifferentiated 
human colon cells) 
Love et al., 2012; Piretet al., 
2012; Gerloff et al., 2013 
Dermal HaCaT (human keratinocytes), 
L929 (murine fibroblast), 
NIH3T3 (mouse embryonic 
fibroblasts) 
Liuet al., 2010; Yildirimer 
et al., 2011; Love et al., 2012 
Inhalation A549 (human lung epithelial 
cells), BEAS-2B human 
bronchial epithelium) 
Simon-Deckers et al., 
2008; Yildirimer et al., 
2011; Love et al., 2012; 
Wanet al., 2012 
Injection and systemic 
exposure 
THP-1 (human monocytes), 
HepG2 (human hepatocytes), 
HEK 293 (human embryonic 
kidney cells) 
Cui et al., 2005; Kawata et 
al., 2009; Su et al., 2010; 
Yildirimer et al., 2011; 
Lankoff et al., 2012; Smith 
et al., 2012;  
2.2.3 In vitro toxicity assessment 
The most commonly in vitro techniques used for studying NM toxicity are based on the 
evaluation of cell viability by analyzing different cellular processes, such as metabolic 
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activity, DNA synthesis, colony formation and membrane integrity (Marquis et al., 
2009). However, the peculiar physico-chemical properties of NMs can alter the results 
of common assays (Monteiro-Riviere et al., 2009; Han et al., 2011; Kroll et al., 2012; Love 
et al., 2012). In particular, NMs can interfere at different levels: (i) optically interference 
with dye or probe; (ii) promoting the conversion of the substrates used in the assays; (iii) 
and influencing enzymatic activity (Kroll et al., 2012). Generally, the interferences due 
to the presence of NMs can be overcame by NM removal from the medium before 
performing in vitro assays (Kroll et al., 2012). In some cases, interferences can be 
mediated by released ions, so resulting to be dependent on NM chemical composition 
(Han et al., 2011; Kroll et al., 2012). Han et al., (2011) have shown that lactate 
dehydrogenase (LDH) assay was not suitable for evaluating cytotoxicity of metallic 
copper NPs (CuNPs). This assay evaluates cellular membrane damages by analyzing the 
activity of LDH released in cell culture medium from damaged cells. CuNPs were found 
to release Cu2+ ions that inhibit LDH activity (Han et al., 2011). Fluorescence-based 
assays can be interfered by metallic NMs or their ions, as for cobalt and nickel. These 
metals quench the fluorescence signal of molecular probes altering in vitro assay results 
(Atherton and Beaumont, 1986; Fabbrizzi et al., 1996). Parallel to viability assays, in vitro 
NM uptake is also important to investigate NM toxicity since it provides a better 
understanding of NM toxicity mechanisms (Marquis et al., 2009). 
2.3 Mechanisms of NM toxicity 
The extensive use of NMs in many application fields raises questions about safety. NMs 
are able to enter into organisms through both physiological and non-physiological 
routes leading to the internalization of non-essential elements (Benetti et al., 2014). 
Once internalized, NMs undergo modifications affecting biodistribution, cellular 
internalization, ion release and toxicity (Benetti et al., 2014).  
From a mechanistic perspective, NMs induce different effects on biological systems that 
can lead to different pathophysiological outcomes (Table 4). 
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TABLE 4. NM effects and potential toxicological outcomes (from Somwanshi et al., 2013) 
Experimental NM effects Potential pathophysiological outcomes 
ROS generation Protein, DNA and membrane injury, oxidative stress 
Oxidative stress Phase II enzyme induction, inflammation, mitochondrial 
perturbation 
Mitochondrial perturbation Inner membrane damage, permeability transition pore 
opening, energy failure, apoptosis, apo-necrosis, cytotoxicity 
Inflammation Tissue infiltration with inflammatory cells, fibrosis, 
granulomas, atherogenesis, acute phase protein expression 
(e.g., C-reactive protein) 
Uptake by reticulo-
endothelial system 
Asymptomatic sequestration and storage in liver, spleen, 
lymphnodes, possible organ enlargement and dysfunction 
Protein denaturation, 
degradation 
Loss of enzyme activity, auto-antigenicity 
Nuclear uptake DNA damage, nucleoprotein clumping, autoantigens 
Uptake in neuronal tissue Brain and peripheral nervous system injury 
Perturbation of phagocytic 
function, "particle overload," 
mediator release 
Chronic inflammation, fibrosis, granulomas, interference in 
clearance of infectious agents 
Endothelial dysfunction, 
effects on blood clotting 
Atherogenesis, thrombosis, stroke, myocardial infarction 
Generation of neoantigens, 
breakdown in immune 
tolerance 
Autoimmunity, adjuvant effects 
Altered cell cycle regulation Proliferation, cell cycle arrest, senescence 
DNA damage Mutagenesis, metaplasia, carcinogenesis 
Reactive oxygen species (ROS) generation and the consequent oxidative stress is 
currently the best-developed paradigm for NM toxicity (Nel et al., 2006). In particular, 
the enhancement of ROS generation by NMs can occur at different levels, including: (i) 
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the chemical reactivity of both particles and related impurities; (ii) the physical 
interaction of NMs with cellular structures, such as the plasma membrane, 
mitochondria and the endoplasmic reticulum; involved in the catalysis of biological 
reduction-oxidation processes; (iii) and the depletion of antioxidant defenses (Unfried 
et al., 2007). Furthermore, the release of transition metal ions deriving from NM 
dissolution or from particle impurities can catalyze Fenton-like reactions (Eq. 1) 
resulting in hydroxyl radicals, the depletion of antioxidant mechanisms and oxidative 
stress generation (Stohs and Bagchi, 1995; Nel et al., 2006). 
MX+ O2 .- → M(X-1) + O2 
2O2 .- + 2H+ → H2O2 + O2 
M(X-1) + H2O2 → M(X) + .OH + OH 
EQUATION 1. Fenton-like reaction generated by a transition metal (M) leading to 
the formation of hydroxyl radical (.OH). (from Stohs and Bagchi, 1995) 
The induction of ROS can also cause oxidative DNA damage that leads to base pair 
mutations, deletions or insertions (Unfried et al., 2007). NMs and their released ions can 
also interact with proteins leading to possible loss of functionality, such as the 
inhibition of enzyme activities (Somwanshi et al., 2013; Benetti et al., 2014). For 
example, Cd2+released by CdSe quantum dots leads to cell death by binding to sulfhydryl 
groups of proteins, especially mitochondrial proteins (Benetti et al., 2014). Moreover, 
genome integrity can also be affected by the inhibition of DNA repair processes. In 
particular, this phenomenon could be relevant considering released soluble metals from 
NMs that interfere with this processes, such as arsenic, iron or copper (Kawanishi et al., 
2002; Kessel et al., 2002). 
With particular reference to insoluble NMs, they have been usually associated to lower 
acute toxic effects (Brunner et al., 2006). However, this property can be also associated 
to accumulation and biopersistence within the biological system and, as a consequence, 
may provoke a range of late effects (Borm et al., 2006; Brunner et al., 2006). 
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Since the biological behavior of NPs depends on parameters such as size, shape, surface 
area and aggregation state, the safety evaluation of NMs cannot rely on the toxicological 
profile of the bulk material that has been historically determined. This has also led to 
conclude that the biological evaluation of NMs should be performed on a case by case 
basis, making more complicated the risk assessment process for NMs. However, no 
experimental study has been dedicated to the possible anticipation of toxicological 
properties of NPs on the basis of certain affinity of their chemical nature. This study 
intends to be a contribution to fill this gap. We consider the case of zerovalent NPs 
derived from three transition metals such as Fe, Co, Ni, that are elements belonging to 
the main transition group or d- block and sharing ferromagnetic properties. Despite 
their chemical similarities, these elements have a different physiological role in living 
systems. Iron plays important role for many biological processes (e.g. oxygen transport 
in vertebrates; catalysis in enzymatic reactions involved in cellular respiration and 
oxidation/reduction processes). Cobalt physiological function is confined to vitamin B12, 
which is involved in different reaction as a coenzyme (i.e. reduction of ribose to 
deoxyribose; the rearrangement of diols and similar molecules; the rearrangement of 
malonyl to succynil; and the transfer of methyl group). In mammals, no essential role of 
nickel has been described yet. However, this metal is involved in some dihydrogen 
reactions in symbiotic anaerobic bacteria and in keeping ammonia balance in some 
plants and animals where it is present in the active site of urease. As nanomaterials, Fe, 
Co and Ni rise great interest for a wide range of applications, such as magnetic fluids, 
catalysis, biomedicine (such as contrast agents in magnetic resonance imaging, 
theranostics agents in tumor therapy and site-specific drug delivery agents), magnetic 
energy storage, information storage and environmental remediation to treat toxic 
contaminants. In relation to their potential nanotechnological applications and to the 
consequent increase in human and environmental exposure, studies dealing with their 
toxicological effect are needed. 
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Objectives 
The present research is focused on the comprehension of the toxicity of a specific 
category of inorganic engineered nanoparticles (NPs): zerovalent FeNPs, CoNPs and 
NiNPs. Three biological systems mimicking inhalation, dermal contact and systemic 
exposure (A549, L929 and HepG2 cell lines) were selected as in vitro models to assess the 
potential toxicity of the NPs and to identify some factors determining the toxicological 
response. The general objective of this work is related to a better understanding of the 
toxic effects induced in different in vitro cell culture models by Fe-, Co- and NiNPs and 
their potential released ionic forms, focusing the attention on some factors affecting the 
biological response. In order to fulfill this purpose the following specific aims were 
pursued: 
I. Physico-chemical characterization of FeNPs, CoNPs, NiNPs. 
The aim is to determine critical parameters (size, shape, agglomeration state) that 
are related to NP behavior and toxicity and are important to allow 
interlaboratory reproducibility. In addition, chemical and biological 
contaminations were also investigated to avoid artifacts. 
II. Dissolution of NPs in culture media.  
The aim is to assess the role of potentially released metal ions in the induction of 
toxicological responses. 
III. In vitro toxicity induced by the NPs on the three cell models. 
The aim is to establish the ranking of toxicity of the individual type of NPs and to 
compare their effects in different cell models. The toxicological analyses were 
performed evaluating cell viability by two assays (ATP and MTS) and establishing 
dose-response curves. 
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IV. Cellular uptake of NPs and their corresponding ions. 
The aim is to correlate the toxic effects induced by the NP s and their ions released 
with the degree of cellular internalization. 
As listed below, results will be presented in different chapter reflecting the individual 
chemical element constituent of the NP considered: 
Chapter 1: Zerovalent iron nanoparticle toxicity 
Chapter 2: The essential role of cobalt ions in mediating cobalt nanoparticle toxicity 
Chapter 3: Nickel nanoparticles: the dual toxicity mechanism 
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Zerovalent iron nanoparticle toxicity 
1 Abstract 
In this study, the toxic effects of zerovalent iron particles (FeNPs) and their relative ions 
(Fe2+ and Fe3+) were investigated in three different in vitro models: carcinomic human 
alveolar basal epithelial cell line (A549) and murine aneuploid fibrosarcoma cell line 
(L929) as in vitro models for inhalation and dermal contact, and human hepatocellular 
liver carcinoma cell line (HepG2) as a liver model. Toxicity results were related to NP 
dissolution and iron internalization. In all the three cell models, FeNPs showed lower 
toxic effects compared to Fe2+ and Fe3+ probably in relation to the absence of free iron 
ions. Furthermore, hepatocytes (HepG2 cells) resulted less susceptible than the other 
two cellular models in agreement with the metal handling by liver and the physiological 
role of iron. Overall, FeNP low toxicity appear in relation to a low dissolution rate and 
to the physiological role of iron. 
2 Introduction 
Iron (Fe) is the second most abundant metal on Earth crust, after aluminum, and belongs 
to d block of transition metals (Cotton and Wilkinson, 1972). It is an essential element 
common to all living organisms, as it is involved in oxidation-reduction catalysis and 
bioenergetics (Da Silva and Williams, 2001). Due to the iron ability to catalyze redox 
reactions and generate oxygen and nitrogen radical species, its homeostasis in biological 
systems is strictly maintained (Emerit et al., 2001; Hentze et al., 2004; Andrews and 
Schmidt, 2007). Fe-based NPs display higher reactivity and magnetism with respect to 
bulk materials and are largely explored to potential applications in many fields, 
including biomedicine, catalysis, data storage and environmental remediation (Laurent 
et al., 2008; Sellers et al., 2010; Yuan and Tasciuc, 2011). Zerovalent iron nanoparticles 
(FeNPs) are characterized by a great reactivity, also compared to other Fe-based NPs 
(such as Fe2O3- and Fe3O4-NPs), and they are proposed as innovative materials in 
environmental remediation to treat toxic contaminants, such as chlorinated 
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hydrocarbons and chromium, trichloroethylene (TCE), arsenic and certain metals and, 
in the presence of oxygen phenols in groundwater (Zhu et al., 2009; Dickinson and Scott, 
2010; Sellers et al., 2010). The high FeNP reactivity may induce toxicological effects 
(Auffan et al., 2008; Lee et al., 2008; Keenan et al., 2009; Li et al., 2010). Different 
investigations have found an oxidative stress-related toxicity of iron-based NPs 
occurring both in extracellular media and inside cells (Lee et al., 2008; Keenan et al., 
2009; Malvindi et al., 2014). Oxidative stress induced by FeNPs is related to the 
oxidation of Fe0 to Fe2+and the subsequent conversion to Fe3+, leading to the formation 
of free radical species, membrane damage, protein carbonylation, and DNA damage 
(Dean and Nicholson, 1994; Winterbourn, 1995; Emerit et al., 2001; Nunez et al., 2001; 
Crichton et al., 2002). Despite the potential FeNP toxicity, cells present well-defined 
homeostatic mechanisms that manage iron in physiological conditions (Crichton et al., 
2002; Andrews and Schmidt, 2007; Dunn et al., 2007). These mechanisms can 
participate in reducing FeNP toxicity. Indeed, it has been observed that astrocytes 
exposed to iron oxide NPs showed no damages probably because of the iron storage 
protein ferritin upregulation (Hohnholt et al., 2013).  
In this work, we investigated the potential toxic effect of FeNPs by using two viability 
assays (MTS and ATP assay) in three different in vitro models: A549 (epithelial cells 
from human lung carcinoma) as in vitro model for inhalation exposure; L929 (fibroblast 
cells from murine subcutaneous connective tissue) as model of dermal contact exposure; 
and HepG2 (epithelial cells from human hepatocellular carcinoma) as liver model. To 
better understand the role of ion release in mediating cell damage, we tested Fe2+ and 
Fe3+ toxicity in the same cell models, and evaluated FeNP dissolution kinetics in the 
experimental conditions. 
3 Materials and Methods 
3.1 Chemicals and reagents 
Metallic zerovalent FeNPs (Product Code:FE-M-03M-NP.025N) were purchased in dry 
form from American Elements® (Merelex Corporation, Los Angeles, CA, USA). They had 
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the following properties as indicated by the supplier: average diameter of 25 nm (with 
size range from 20 to 40 nm), specific area of 30-50 m2/g and spherical shape. Acid 
solution of HNO3 (67-69% SpA) and HCl (33-36% UpA) were purchased from Romil 
(Cambridge, UK). Reagents for biological characterization were: Tryptic Soy Agar (TSA; 
Biolife Italiana S.r.l.; Milan, IT); Venor®GeM Mycoplasma detection kit (Minerva 
Biolabs, Berlin, De), GoTaq® DNA polymerase, 5X Colorless GoTaq® Reaction Buffer, 
Blue/Orange 6X loading dye, 100bp DNA ladder (Promega; Madison, WI, USA); all 
reagents for the detection of endotoxins were purchased from Charles River 
Laboratories International, Inc (Charleston, SC, USA). FeSO4·7H2O (Product Code: 
F8633), FeCl3·6H2O (Product Code: 31232), Triton X-100, and agarose were purchased 
from Sigma–Aldrich (Gillingham, UK). Sodium Dodecyl Sulphate (SDS), staurosporine 
(STS), Trizma® base primary standard and buffer, ethylenediaminetetraacetic acid 
disodium salt dehydrate (EDTA), acetic acid (puriss., 99-100%), ethidium bromide 
solution (10 mg/mL in H2O) and Phosphate Buffer Saline (PBS)were purchased from 
Sigma-Aldrich (St. Louis, MO, USA). Cytotoxicity was tested with CellTiter 96 AQueous 
Non-Radioactive Cell Proliferation Assay kit Promega (Madison, WI, USA) and ATPlite 
(Perkin Elmer, Waltham, MA, USA). Human lung carcinoma epithelial cells (A549), 
murine subcutaneous connective tissue fibroblast cells (L929) and human 
hepatocellular carcinoma epithelial cells (HepG2) were obtained from American Type 
Culture Collection (Manassas, VA, USA). Solutions for cell culture were: Ham’s F-12K 
and Eagle Minimum Essential Medium (EMEM), fetal bovine serum (FBS), penicillin-
streptomycin solution, L-glutamine, phosphate buffered saline (PBS), Dulbecco’s 
phosphate buffered saline with calcium and magnesium (DPBS), Trypsin-EDTA, all 
purchased from Lonza (Basel, CH). Protein quantification was conducted by using 
MicroBCATM Protein Assay Kit (Thermo Scientific; Rockford, IL, USA).  
3.2 FeNP characterization 
FeNPs were characterized for chemical and biological contaminations and 
morphological properties.  
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3.2.1 Chemical characterization 
To detect FeNP chemical impurities a semi-quantitative analysis (ranging from 6 to 240 
amu) by inductively coupled plasma mass spectrometry (ICP-MS; NexION 300D, Perkin 
Elmer Inc.; Waltham, MA, USA) was conducted. In particular, dry FeNPs were 
solubilized with a microwave assisted acid digestion. NPs were weighted in specific 
Teflon vessels and suspended with 75% HNO3 (67-69% SpA) and 25% HCl (33-36% UpA). 
Blank samples were added to the analysis to detect possible environmental 
contaminations. Microwave digestion was performed by using a Mars V 
microwave(CEM Corporation; Matthews, NC, USA)and the program used has foreseen 
two different steps: i) increase of temperature until 175°C in 5.5 minutes and ii) 
maintaining of 175°C for 4.5 minutes to complete digestion. After this acid digestion, 
solutions were diluted with ultrapure water (18,3 MΩ·cm-1) and analyzed by ICP-MS 
with a semi-quantitative method. The most concentrated elements detected were 
quantified by using an external calibration curve. To limit signal drift, a rhodium 
solution (10 μg/L) as internal standard was added online to each standard and sample 
solutions.  
3.2.2 Biological contaminations 
In order to assess microbiological contaminations and endotoxins, FeNPs were 
suspended at the concentration of 1 mg/mL in sterile water and ultrasonicated for 4 
minutes at 50% of amplitude, corresponding to 28000 J (Misonix S-4000 Ultrasonic 
Liquid Processors, Qsonica LLC.; Newtown, CT, USA). To detect possible generic fungal 
and bacterial contaminations, 100 μL of the suspensions were plated in TSA plates and 
incubated at 37°C for 72 h. After the incubation, the presence of colonies on the plates 
was verified. In addition, mycoplasma contaminations were specifically tested using the 
Venor®GeM Mycoplasma detection kit according to manufacturer’s instructions. 
Briefly, the possible mycoplasma contamination was detected by amplifying the highly 
conserved 16S rRNA coding region that generate an amplicon of approximately 267 bp. 
Internal DNA control of 191 bp was present in each sample, in order to confirm a 
successfully performed polymerase chain reaction (PCR). After PCR (Mastercycler; 
Eppendorf s.r.l.; Milan, IT), a 1.5% agarose gel in a Tris/acetic/ EDTA buffer (40 mMTris, 
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20 mM acetic acid and 1 mM EDTA) including ethidium bromide, as DNA staining, was 
cast and 10 μL of each PCR reaction, mixed with 2μL of Blue/Orange 6X loading dye were 
loaded for electrophoresis (Peqlab Biotechnologie GmbH; Erlangen, DE); a 100bp DNA 
ladder was used. At the end of the electrophoresis, gel were observed by a UV 
transilluminator (UVITEC; Cambridge, UK) and photographed. 
The presence of endotoxin on suspension supernatants was tested by using the Limulus 
Amebocyte Lysate (LAL) Kinetic-turbidimetric method (Charles River Endosafe; 
Charleston, SC, USA). This analysis was conducted in a 96-well plate and consisted in 
optical density (λ = 340 nm) measurements over time with the microplate reader 
(Synergy4, Bio-Tek Instruments Inc.; Winooski, VT, USA). The assay included a 
standard curve of Escherichia coli endotoxin (from 5 to 0.005 EU/mL) and different 
dilutions of supernatants with and without standard in order to evaluate possible 
interferences. In particular, the onset time, which means the time required for the 
absorbance to increase significantly over the background (0.05 OD units), was calculated 
and a linear relation between standard endotoxin concentrations and onset time was 
established in order to calculate sample endotoxin concentrations. 
3.2.3 Morphological characterization 
Morphological analyses were performed with two different techniques. In particular, 
FeNPs were suspended in sterile water at the concentration of 1 mg/mL, ultrasonicated 
(Misonix S-4000 Ultrasonic Liquid Processors, Qsonica LLC.; Newtown, CT, USA) for 4 
minutes at 50% of amplitude (corresponding to 28000J). This suspension was diluted in 
water at the concentration of 100 μg/mL to be examined by Transmission Electron 
Microscopy (TEM; FEI Tecnai 12 G2 electron microscope, FEI Co.; Eindhoven, NL) with 
Twin lens configuration after deposition on carbon coated, mesh 400 copper grids and 
left to dry. Micrographs were recorded on a side-mounted Morada CCD (Olympus Soft 
imaging Solutions GmbH, Münster, Germany) at magnifications ranging from 42000× 
to 265000×. To evaluate the aggregation state of NPs in suspension, dilution at the 
concentration of 10 μg/mL in cell culture complete media and water were done to be 
analyzed with the ZetasizerNano ZS Dynamic Light Scattering (DLS; Malvern 
Instruments; Malvern, UK). A blank (only cell culture media) sample were analyzed too. 
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For the DLS analysis, suspensions were equilibrated at 25°C for 3 minutes and five 
measurements for each sample were performed.  
3.3 FeNP dissolution 
FeNP suspensions in cell culture media were analyzed for ion release under our 
experimental conditions. Different suspensions (0, 10, 100 and 1000 μg/mL) of FeNPs in 
cell culture media were prepared from a stock suspension (10 mg/mL) that was 
ultrasonicated for 4 minutes at 50% of amplitude (corresponding to 28000 J). Each 
suspension was incubated at 37°C, 5% CO2 and 90% of humidity for 0, 6, 24 and 48 h in 
24-well plates (1mL for each well). At the end of incubation NPs were removed from 
suspensions by collecting samples in 2 mL tubes, centrifuging twice at 16000 g for 10 
minutes and finally ultracentrifuging (OptimaTM L-100XP Ultracentrifuge; Beckman 
Coulter; Urbana, IL, USA) for 2 hours at 300000 g at 4°C. Ultracentrifugation was 
conducted in polycarbonate tubes (Beckman Coulter; Urbana, IL, USA) with the rotor 
type 70.1.Ti (Beckman Coulter). Supernatants were collected and diluted with a 2% 
HNO3 solution prior to being analyzed for iron quantification with ICP-MS (NexION 
300D, Perkin Elmer; Waltham, MA, USA).Simultaneously, 100 μg/mL solutions of Fe2+ 
and Fe3+ in cell culture media and ddH2O were analyzed to monitor the ion behavior 
during the experiment. In addition, not ultracentrifuged NP suspensions and ion 
solutions were quantitatively analyzed by ICP-MS. In particular, ion solutions were 
simply diluted in 2% HNO3 solution in the calibration curve concentration range, 
whereas, NP suspensions were solubilized by microwave acid digestion (Mars V,CEM). 
500 μL of each suspension were transferred in specific Teflon vessels and 10 mL of 
HNO3(67-69% SpA) were added. Blank samples were included to the analysis to detect 
possible environmental contaminations. Microwave digestion program has foreseen 
two different steps: i) increase of temperature until 175°C in 7 minutes and ii) 
maintaining of 175°C for 3 minutes to complete digestion. After this acid digestion, 
solutions were diluted with ultrapure water (18,3 MΩ·cm-1) and analyzed by ICP-MS 
(NexION 300D, Perkin Elmer; Waltham, MA, USA). ICP-MS quantitative analyses of 
ionic release and NP and ion solution were performed using an external calibration 
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curve. To limit signal drift, a rhodium solution (10 μg/L) as internal standard was added 
online to each standard and sample solutions.  
3.4 Cell viability analyses 
3.4.1 Cell culture and sub-culturing procedure 
A549, L929 and HepG2 cells were maintained following ATCC indications. A549 cells 
were cultured in Ham’s F12K medium with the addition of 10 % FBS, 100 units/mL 
streptomycin and 100 μg/mL penicillin. HepG2 and L929 cells were cultured in EMEM 
with the addition of 10%FBS, 100 units/mL streptomycin and 100 μg/mL penicillin and 
2mM L-glutamine. All the three cell lines were kept at 37°C, 5% CO2 and 90% of 
humidity for maintenance and for experiments.  
3.4.2 FeNP, Fe2+ and Fe3+toxicity  
In order to evaluate the cytotoxic effects of FeNPs, Fe2+ and Fe3+, cells were seeded in 96-
well microplate and, 24h after seeding, treated with different concentrations of NP and 
ions for 6, 24 and 48 h. The seeding densities of cells were those at which cells 
proliferated overtime: 5000 cell/well for A549 and L929 cells, and 15000 cell/well for 
HepG2 cells. Treatment solutions or suspensions were freshly prepared before each test. 
In particular, NPs were suspended in sterile water and ultrasonicated for 4 minutes at 
50% of amplitude (corresponding at 28000 J) in order to make a stock suspension that 
was diluted in the proper cell culture media without exceeding the 10% of the total 
volume of the treatment. Ion stock solutions were prepared in ddH2O, filtered with 0.22 
μm pore size filter and diluted in cell culture media as NP stock suspensions. 
Experiments were performed in triplicate. Viability was assessed after the removal of 
cell culture media and washing of cells with DPBS in order to eliminate possible NP 
interferences (Kroll et al., 2012). The two assays used were: MTS assay and ATP assay 
were performed according to manufacturer’s instructions. The MTS assay analyzes the 
conversion of a tetraziolium salt 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H] (MTS) into its reduced and soluble 
formazan form by mitochondrial enzyme of metabolically active cells and was 
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evaluated by recording absorbance at 490 nm. ATP assay is based on light production 
caused by the reaction of ATP with added luciferase and D-luciferin and quantify the 
ATP content. Both absorbance and luminescence were recorded with the Synergy4 
microplate reader (Bio-Tek Instruments). 
3.4.3 Late effects 
Possible late effects induced by of FeNPs, Fe2+ and Fe3+ exposure were analyzed by 
incubating cells with each iron compound for 6 h, removing treatments and replacing 
with fresh culture media, after washing cells twice with DPBS, and finally analyzing 
ATP content at 24 and 48 h post treatment.  
3.4.4 Cellular uptake 
Cellular uptake of FeNPs, Fe2+and Fe3+was quantitatively analyzed by ICP-MS (NexION 
300D, Perkin Elmer). Cells were seeded in 24-well plate at densities 10 times higher 
compared to those used in 96-well plate experiments. After 24h the seeding, cells were 
treated with 10 μg/mL of FeNP or ions for 24 h from stock suspensions prepared 
similarly to cytotoxicity tests. At the end of the exposure, cells were washed three-times 
with PBS to remove NPs and ions not internalized. Cells were then detached with 200 
μL of Trypsin-EDTA and collected with 800 μL of PBS to be analyzed for protein 
quantification and uptake. Samples dedicated to protein quantification were 
centrifuged at 16000 g for 5 minutes. Then, supernatants were discarded and cell pellets 
were lysed with a lysis solution containing PBS 1X, 1% Triton X-100 and 1% SDS. Protein 
quantification was conducted using the microBCA assay. Bovine Serum Albumin (BSA) 
provided by the kit was diluted to prepare different standards in the linear 
concentration range of 10-40 μg/mL and manufacturer’s instructions were followed. To 
analyze uptake, samples were centrifuged at 400 g for 15 minutes. Once supernatants 
were discarded pellets were digested by adding 1 mL of aqua regia (fresh mixture of 
concentrated nitric acid and hydrochloric acid in the volume ratio 1 : 3).After an 
overnight incubation at room temperature, samples were incubated 12 h at 70°C in 
Thermoblock (FALC Instruments; Treviglio, IT) and finally diluted in ultrapure H2O 
(18,3 MΩ·cm-1). The obtained solutions were quantitatively analyzed by ICP-MS 
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(NexION 300D, Perkin Elmer; Waltham, MA, USA) by using the Dynamic Reaction Cell 
(DRC) method with a standard calibration curve and a rhodium solution as internal 
standard. 
3.5 Statistical analyses 
Statistical analyses were performed using Origin Pro 8.0 software (OriginLab; 
Northampton, MA, USA). Cytotoxicity results were fitted by sigmoid functions and 
EC50 values were calculated. Where bimodal dose-response curves appeared more 
appropriate, F-tests were performed to compare unimodal and bimodal models. 
Statistical significances were determined by ANOVA analysis (P value < 0.05).  
4 Results 
4.1 FeNP characterization 
The analysis of chemical purity of FeNPs showed the presence of two main metal 
contaminants: cobalt (Co) and manganese (Mn) (Table 1). On the contrary, 
microbiological contaminations were absent and endotoxin levels were below 0.01 
EU/mL (corresponding to levels detected for sterile water). 
TABLE 1. Elemental FeNP contaminations. 
Element μg/g 
a
 ± SD %
 b
 ± SD
Co 196 ± 1 0.0196 ± 0.0001
Mn 61.7 ± 0.8 0.0062 ± 0.0001
Concentration
 
a: dry weight 
b: % expressed as w/w (dry weight)  
SD: standard deviation (mean of three determinations). 
An accurate primary size distribution was hampered because of particle aggregation, as 
observed from TEM images in which FeNPs appeared polydispersed in size, in a 
crystalline form and spheroidal in shape (Fig. 1). Aggregation and polydispersion were 
confirmed by DLS analysis (Fig. 2). 
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FIGURE 1. TEM images of FeNPs at different instrumental magnifications: 
A) 97000 ×; B) 195000 × 
 
FIGURE 2. DLS size distribution performed in A) water (PdI = 0.543); B) Ham’s F-
12K medium (PdI = 0.678)and C) EMEM medium (PdI = 0.698). 
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4.2 FeNP dissolution 
Before evaluating dissolution of FeNPs in water and cell culture media, the effect of 
ultracentrifugation on both Fe2+ and Fe3+ was investigated. While in aqueous solution 
ultracentrifugation did not affect ion solubility, in the presence of cell culture media 
iron concentration in solution was drastically reduced (Fig. 3). 
 
FIGURE 3. Analysis of concentrations Fe2+ (A) and Fe3+ (B) before and after 
ultracentrifugation in water and cell culture media. Data are expressed as mean 
of three different measurements, each of them expressed as % of stock solution 
concentrations. Error bars represent standard deviations of three different 
measurements. * Significant different from stock solution (P value < 0.05) 
Furthermore, ion precipitation occurred during the first 6 h (P < 0.05), while no 
differences were noted for longer incubation times (Fig. 4). However, Fe2+ in water did 
not undergo precipitation (Fig. 4A) 
 
FIGURE 4. Ions in solutions over time in water and cell culture media (Ham’s F-
12K and EMEM). A) Fe2+; B) Fe3+. Data are expressed as means of three 
measurements and error bars represents standard deviations. 
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EMEM cell culture medium induced iron precipitation more than Ham’s F-12K (Fig. 3, 
4). Despite precipitation phenomena, probably due to the formation of iron hydroxides, 
FeNP dissolution kinetics were studied. After ultracentrifugation, the level of iron in the 
soluble fraction did not change significantly compared to iron in cell culture media (Fig. 
5). 
 
FIGURE 5. Ions released by FeNPs in Ham’s F-12K medium over time. Data are 
expressed as means of three measurements and error bars represents standard 
deviations. 
4.3 FeNP, Fe2+ and Fe3+ toxicity 
Cell viability after exposure to FeNP, Fe2+ and Fe3+ was performed by using two different 
viability assays. Where possible, dose-response curves were fitted (Fig. 6, 7, 8) and EC50 
was calculated (Table 2). ATP and MTS assays showed similar dose- and time-dependent 
effects of FeNPs, Fe2+and Fe3+ in the three in vitro models (Fig. 6, 7, 8). In particular, 
FeNPs did not induce a complete reduction of metabolic activity or ATP content, while 
the two ionic forms caused a total reduction of viability from 24 h of exposure. However, 
FeNP effect occurred at lower concentration with respect to Fe2+and Fe3+ ions. The main 
difference between the two assays was related to FeNP toxicity on HepG2 cells. In 
HepG2 cells, the reduction of ATP content was not confirmed by a reduction in 
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HepG2 cells resulted to be the less susceptible in vitro model, while A549 showed high 
sensitivity to the treatments (Fig.6, 7, 8; Table 2).  
 
FIGURE 6. Dose-response curves obtained by treating A549 cells with FeNPs, 
Fe2+ and Fe3+ for 6 (A, D), 24 (B, E) and 48h (C, F). Panels A, B, C refer to ATP 
assay, while panels D, E, F refer to MTS assay. Data are expressed as mean of 
three independent experiments and error bars represent standard deviations. 
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FIGURE 7. Dose-response curves obtained by treating L929 cells with FeNPs, 
Fe2+ and Fe3+ for 6 (A, D), 24 (B, E) and 48 h (C, F). Panels A, B, C refer to ATP 
assay, while panels D, E, F refer to MTS assay. Data are expressed as mean of 
three independent experiments and error bars represent standard deviations. 
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FIGURE 8. Dose-response curves obtained by treating HepG2 cells with FeNPs, 
Fe2+ and Fe3+ for 6 (A, D), 24 (B, E) and 48h (C, F). Panels A, B, C refer to ATP 
assay, while panels D, E, F refer to MTS assay. Data are expressed as mean of 
three independent experiments and error bars represent standard deviations. 
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TABLE 2. EC50 values of FeNPs, Fe2+ and Fe3+ in the three cell models at 6, 24 and 48 h. 
6 h 24 h 48 h 6 h 24 h 48 h 6 h 24 h 48 h
FeNP 557.4 40.1 21.5 31.3 52.3 102.4 57 60.4 16.4
Fe
2+ 114/609* 201.8 153.7 77.3 161.1 176 169.2 139.2 212
Fe
3+ 300.4 224 205.2 105/449* 213.2 111.6 122/420* 235.7 266.3
FeNP N.E 32.3 30.8 N.E. 61.1 221.6 N.E. N.E. N.E.
Fe
2+ 604.6 238.7 229.2 202.1 179.7 184.7 259.4 229 269.8
Fe
3+ 305.5 218 215.5 425.9 12.5/398* 249.2 317.3 310.3 269.6
ATP assay
MTS assay
EC50 (μg/mL)
Compound
A549 L929 HepG2
 
N.E.: no effect. 
* Double EC50 values calculated from bimodal dose-response curves. 
4.4 Late effects 
In order to better understand the intracellular behavior of FeNPs, we treated cells for 6 
h and then, after 24 h and 48 h of recovery, we observed their effects on ATP content. 
Late effects following short incubation times showed that FeNP toxicity lost its time-
dependency, considering maximum effect that corresponded to that observed after 6 h 
treatment (Fig. 9A, 9B, 10A, 10B). Considering Fe2+ and Fe3+, they induced a reduced 
toxicity but still time-dependent always considering maximum effects, as in some cases 
dose-response curves could not be obtained (Fig. 9C, 9D, 9E, 9F, 10C, 10D, 10E, 10F; Table 
3). 
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FIGURE 9. FeNP (A, B), Fe2+ (C, D) and Fe3+ (E, F) toxicity on L929 cells measured 
by ATP assays after the removal of treatments (6 h post treatments). ATP assay 
were performed after 24 h (A, C) and 48 h (B, D) from treatment. Dose-response 
curves obtained by treating cells with FeNPs, Fe2+ and Fe3+ for 6, 24 and 48 h 
were also reported. Data are expressed as mean of three independent 
experiments and error bars represent standard deviations. 
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FIGURE 10. FeNP (A, B), Fe2+ (C, D) and Fe3+ (E, F) toxicity on HepG2 cells 
measured by ATP assays after the removal of treatments (6 h post treatments). 
ATP assay were performed after 24 h (A, C) and 48 h (B, D) from treatment. 
Dose-response curves obtained by treating cells with FeNPs, Fe2+ and Fe3+for 6, 
24 and 48 h were also reported. Data are expressed as mean of three 
independent experiments and error bars represent standard deviations. 
 
 
0
20
40
60
80
100
120
A
T
P
 c
o
n
te
n
t 
(%
 c
o
n
tr
o
l)
[Ni]
 Removal
 Removal fit
 6 h
 Fit 6 h
 24 h
 Fit 24 h
 48 h
 Fit 48 h
A
0 1 5
1
0
5
0
1
0
0
5
0
0
1
0
0
0
5
0
0
0
[FeNP] µg/mL
0
20
40
60
80
100
120
A
T
P
 c
o
n
te
n
t 
(%
 c
o
n
tr
o
l)
[Ni]
 Removal
 Removal fit
 6 h
 Fit 6 h
 24 h
 Fit 24 h
 48 h
 Fit 48 h
B
0 1 5
1
0
5
0
1
0
0
5
0
0
1
0
0
0
5
0
0
0
[FeNP] µg/mL
0
20
40
60
80
100
120
140
A
T
P
 c
o
n
te
n
t 
(%
 c
o
n
tr
o
l)
[Ni]
 Removal
 6 h
 Fit 6 h
 24 h
 Fit 24 h
 48 h
 Fit 48 h
C
0 1 5
1
0
5
0
1
0
0
5
0
0
[Fe] µg/mL
0
20
40
60
80
100
120
140
A
T
P
 c
o
n
te
n
t 
(%
 c
o
n
tr
o
l)
[Ni]
 Removal
 Removal fit
 6 h
 Fit 6 h
 24 h
 Fit 24 h
 48 h
 Fit 48 h
D
0 1 5
1
0
5
0
1
0
0
5
0
0
[Fe] µg/mL
0
20
40
60
80
100
120
140
A
T
P
 c
o
n
te
n
t 
(%
 c
o
n
tr
o
l)
[Ni]
 Removal
 6 h
 Fit 6 h
 24 h
 Fit 24 h
 48 h
 Fit 48 h
0 1 5
1
0
5
0
1
0
0
5
0
0
[Fe] µg/mL
E
0
20
40
60
80
100
120
140
A
T
P
 c
o
n
te
n
t 
(%
 c
o
n
tr
o
l)
[Ni]
 Removal
 6 h
 Fit 6 h
 24 h
 Fit 24 h
 48 h
 Fit 48 h
0 1 5
1
0
5
0
1
0
0
5
0
0
[Fe] µg/mL
F
CHAPTER 1 
53 
 
TABLE 3. Maximum effect and EC50 values of L929 and HepG2 cells after 6 h of 
exposure with Co compound and 24 and 48 h of recovery. 
24 h 48 h 24 h 48 h
FeNP 45 66 76.9 74.2
Fe
2+ 6.9 0 39.4 13
Fe
3+ 41 13.3 0 0
FeNP 123 70.2 6.1 48.4
Fe
2+ N.D. 327 N.D. 251
Fe
3+ N.D. N.D. N.D. N.D.
EC50 (μg/mL)
Max effect (% control)
L929 HepG2
Compound
 
N.D: not determined 
4.5 Cellular uptake 
As different toxicities were observed among cell lines, the intracellular concentration of 
iron was quantified, as a higher cell susceptibility could be related to the higher uptake. 
With this respect, iron uptake was quantified by ICP-MS and the resulting 
concentrations normalized for protein concentration. As shown in Fig. 9, cell treated 
with FeNPs internalized iron more efficiently than cells treated with Fe2+and Fe3+in all 
the three cell models. In addition, the extent of internalization was different among in 
the three cell models. In particular, FeNPs were significantly less internalized by HepG2 
cells compared to A549 and L929 cells, which rather showed a similar uptake (Fig.9). 
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FIGURE 11. Uptake of FeNPs, Fe2+ and Fe3+in A549, L929 and HepG2 cells. Data 
are expressed as ng of Fe for μg/mL of proteins and error bars are standard 
deviations. *Significant difference among cell models (P < 0.05). 
5 Discussion 
FeNPs aggregates in both water and cell culture media, as already reported for bare 
metallic NPs (Oberdörster et al., 2007; Teeguarden et al., 2007). This process hampered 
NP characterization, such as particle size distribution and specific surface area. 
Aggregation can also modify size-related NP properties as aggregated NPs act as bigger 
particles (Borm et al., 2006; Buzea et al., 2007; Oberdörster et al., 2007). In particular, 
aggregation reduces NP dissolution decreasing specific surface area, and affects the 
cellular dose as bigger particles settle more rapidly and, as a consequence, they can 
easily interact with cells (Teeguarden et al., 2007; Dhawan and Sharma, 2010; Fadeel and 
Garcia-Bennett, 2010; Misra et al., 2012). Dissolution is a fundamental property in 
determining metal NP toxicity. Therefore, ion release under experimental conditions 
was evaluated. In this work, we have chosen one of most common methodological 
approach for assessing dissolution. Soluble iron was separated from FeNPs by 
ultracentrifugation and then quantified them by ICP-MS (Zook et al., 2011; Misra et al., 
2012; Bregoli et al., 2013). Ultracentrifugation appears to increase Fe2+and Fe3+ 
precipitation, in particular in cell culture media. However, Fe ions precipitation occurs 
spontaneously in the presence of dioxygen at pH 7 because of iron hydroxide formation 
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(Da Silva and Williams, 2001). This process could interfere with the detection of ions 
release by NPs; accordingly, the failure to detect Fe ions in solution could be due to the 
precipitation of the ions themselves instead of the lack of dissolution processes. 
Administration of FeNPs induces lower toxic effects than Fe2+ and Fe3+ ions on the three 
in vitro models, probably due to the low ability of NPs to release ions. The low 
dissolution of FeNPs can also explain the time-independency of late effects observed 
after short exposure with FeNPs (6 h). This suggests that FeNP toxicity could be 
independent from ion release and depend on other mechanisms such as oxidative stress 
though the oxidation of NP surface (Auffan et al., 2009; Studer et al., 2010). As a 
consequence, time-dependency of FeNP toxicity could be related to the increase of NP 
internalization rather than ion release. Furthermore, hepatocytes (HepG2 cells) result 
less susceptible than the other two cellular models. HepG2 cells have been used as liver 
model. Hepatocytes are specialized cells involved in maintaining systemic metal 
homeostasis via well-defined molecular mechanisms and possess an efficient 
antioxidant mechanisms (Crichton et al., 2002; Andrews and Schmidt, 2007). Therefore, 
HepG2 cells are able to manage iron, both as FeNPs and ions, more promptly than A549 
and L929 cells. Although Fe ions induced higher effects than FeNPs, the latter have an 
impact on cell viability at lower concentrations. This could be due to the ability of these 
cells to respond to low concentrations of Fe2+ and Fe3+ by activating homeostatic 
pathways, and to FeNP toxic mechanisms probably independent from ion release. 
In conclusion, FeNPs induce low toxicity in all three cell models. This in vitro moderate 
effect could be related to the very low NP dissolution occurring both in cell culture 
media and inside cells and to the presence of an homeostatic mechanisms that can 
decrease the effects of the released ions, as described in Fig. 12. On the other hand, the 
observed low in vitro FeNP toxicity may not reflect the in vivo condition due to possible 
relation of low dissolution with biopersistance, high accumulation, low clearance and 
chronic effects (Borm et al., 2006). 
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FIGURE 12. Possible mechanism for FeNP toxicity. When cells are exposed to 
FeNPs, they can internalize them. Once FeNPs are internalized inside cells, 
they can release Fe2+ that can be used for the incorporation in iron-dependent 
proteins or stored in ferritin, reducing the toxic effects of released ions. The 
effects on cell viability (i.e. the reduction of ATP content and metabolic activity) 
seem to be related to processes due to the presence of NPs inside cells and 
probably occurring at their surface. 
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The essential role of cobalt ions in mediating cobalt 
nanoparticle toxicity 
1 Abstract 
In this study, we analyzed the toxic effects of cobalt nanoparticles (CoNPs) and its 
relative ion (Co2+). In particular, toxicity was evaluated in three different in vitro 
models: carcinomic human alveolar basal epithelial cell line (A549) and murine 
aneuploid fibrosarcoma cell line (L929) as in vitro models for inhalation and dermal 
contact, and human hepatocellular liver carcinoma cell line (HepG2) as a liver model. 
Furthermore, dissolution kinetics and cellular uptake were analyzed. CoNPs and Co2+ 
showed similar dose-response curves. This similarity can be related to high Co released 
by NPs. Differences in cell susceptibility were found (A549 > L929 > HepG2), but did not 
result to be related to differences in intracellular Co concentrations. Overall, our 
findings suggest that CoNP toxicity is closely related to NP dissolution process. 
2 Introduction 
Cobalt (Co) is a transition element of the d block (Cotton and Wilkinson, 1972; Da Silva 
and Williams, 2001). From a physiological point of view, the role of cobalt in biological 
systems is mediated by vitamin B12 or cobalamin, which is involved as a coenzyme in 
different biochemical reactions, such as the reduction of ribose to deoxyribose; the 
rearrangement of diols and similar molecules; the rearrangement if malonyl to succynil; 
and the transfer of methyl group (Roth et al., 1996; Da Silva and Williams, 2001). As 
nanoparticle, cobalt (CoNP) has high magnetism and can find application in different 
fields, such as industrial (as information storage, magnetic fluids and catalysts) and 
biomedical applications (in particular as highly sensitive magnetic resonance imaging 
contrast agents) (Colognato et al., 2008; Horev-Azaria et al., 2011). Several studies 
reported a dose- and time-dependent toxicity of CoNPs on different cellular models 
(Peters et al., 2004; Mo et al., 2008; Wan et al., 2008; Kwon et al., 2009; Ponti et al., 2009; 
Horev-Azaria et al., 2011; Jiang et al., 2012; Wan et al., 2012; Sabbioni et al., 2014a). From 
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a mechanistic point of view, CoNPs toxicity and genotoxicity are due to ROS production 
and inhibition of antioxidant defenses (Wan et al., 2008; Jiang et al., 2012; Vales et al., 
2013; Wan et al., 2012; Sabbioni et al., 2014a). Since cobalt ions are known to be toxic, 
(Simonsen et al., 2012), the release of Co2+ from CoNPs is usually considered a 
predominant factor in inducing toxicity (Kwon et al., 2009; Ponti et al., 2009; Jiang et al., 
2012). 
The aim of this work was to better understand the factors that affect CoNP toxicity. To 
achieve this goal, we compared CoNP and Co2+ dose-response curves obtained with two 
viability assays (MTS and ATP assay) in three different cell models: A549 (epithelial cells 
from human lung carcinoma) as in vitro model for inhalation exposure; L929 (fibroblast 
cells from murine subcutaneous connective tissue) as model of dermal contact exposure; 
and HepG2 (epithelial cells from human hepatocellular carcinoma) as liver model. Then, 
late effects induced in the three model have been evaluated. These results were 
explained in light of ion release kinetics and cellular uptake. 
3 Materials and Methods 
3.1 Chemicals and reagents 
Metallic zerovalent CoNPs (Product Code:CO-M-0251M-NP.030N) were purchased in 
dry form from American Elements® (Merelex Corporation, Los Angeles, CA, USA). They 
had the following properties, as indicated by the supplier: average diameter of 28 nm 
(with size range from 2 to 60 nm), specific area of 40-60 m2/g and spherical shape. Acid 
solution of HNO3 (67-69% SpA) and HCl (33-36% UpA) were purchased from Romil 
(Cambridge, UK). Reagents for biological characterization were: Tryptic Soy Agar (TSA; 
Biolife Italiana S.r.l.; Milan, IT); Venor®GeM Mycoplasma detection kit (Minerva 
Biolabs, Berlin, De), GoTaq® DNA polymerase, 5X Colorless GoTaq® Reaction Buffer, 
Blue/Orange 6X loading dye, 100bp DNA ladder (Promega; Madison, WI, USA); all 
reagents for the detection of endotoxin were purchased from Charles River Laboratories 
International, Inc (Charleston, SC, USA). CoCl2 (Product Code: 60818), vitamin B12 
(Product Code:V6629) Triton X-100 and agarose were purchased from Sigma–Aldrich 
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(Gillingham, UK). Sodium Dodecyl Sulphate (SDS), staurosporine (STS), Trizma® base 
primary standard and buffer, ethylenediaminetetraacetic acid disodium salt dehydrate 
(EDTA), acetic acid (puriss., 99-100%), ethidium bromide solution (10 mg/mL in H2O) 
and Phosphate Buffer Saline (PBS)were purchased from Sigma-Aldrich (St. Louis, MO, 
USA). Cytotoxicity was tested with CellTiter 96 AQueous Non-Radioactive Cell 
Proliferation Assay kit Promega (Madison, WI, USA) and ATPlite (Perkin Elmer, 
Waltham, MA, USA). Human lung carcinoma epithelial cells (A549), murine 
subcutaneous connective tissue fibroblast cells (L929) and human hepatocellular 
carcinoma epithelial cells (HepG2) were obtained from American Type Culture 
Collection (Manassas, VA, USA). Solutions for cell culture were: Ham’s F-12K and Eagle 
Minimum Essential Medium (EMEM), fetal bovine serum (FBS), penicillin-
streptomycin solution, L-glutamine, phosphate buffered saline (PBS), Dulbecco’s 
phosphate buffered saline with calcium and magnesium (DPBS), Trypsin-EDTA, all 
purchased from Lonza (Basel, CH). Protein quantification was conducted by using 
MicroBCATM Protein Assay Kit (Thermo Scientific; Rockford, IL, USA).  
3.2 CoNP characterization 
CoNPs were characterized for chemical and biological contaminations and 
morphological properties.  
3.2.1 Chemical characterization 
To detect CoNP chemical impurities a semi-quantitative analysis (ranging from 6 to 240 
amu) by inductively coupled plasma mass spectrometry (ICP-MS; NexION 300D, Perkin 
Elmer Inc.; Waltham, MA, USA) was conducted. In particular, dry NPs were solubilized 
with a microwave assisted acid digestion. NPs were weighted in specific Teflon vessels 
and suspended with 75% HNO3 (67-69% SpA) and 25% HCl (33-36% UpA). Blank samples 
were added to the analysis to detect possible environmental contaminations. 
Microwave digestion was performed by using a Mars V microwave (CEM Corporation; 
Matthews, NC, USA) and the program used has foreseen two different steps: i) increase 
of temperature until 175°C in 5.5 minutes and ii) maintaining of 175°C for 4.5 minutes to 
complete digestion. After this acid digestion, solutions were diluted with ultrapure 
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water (18,3 MΩ·cm-1) and analyzed by ICP-MS with a semi-quantitative method. The 
most concentrated elements detected were quantified by using an external calibration 
curve. To limit signal drift, a rhodium solution (10 μg/L) as internal standard was added 
online to each standard and sample solutions.  
3.2.2 Biological contaminations 
In order to avoid microbiological contaminations that could influence cellular 
responses during experiments, microbiological contaminations and endotoxin 
presence were tested on CoNPs suspensions. In particular, NPs were suspended at the 
concentration of 1 mg/mL in sterile water and ultrasonicated for 4 minutes at 50% of 
amplitude, corresponding to 28000 J (Misonix S-4000 Ultrasonic Liquid Processors, 
Qsonica LLC.; Newtown, CT, USA). To detect possible generic fungal and bacterial 
contaminations, 100 μL of the suspensions were plated in TSA plates and incubated at 
37°C for 72 h. After the incubation, the presence of colonies on the plates was verified. 
In addition, mycoplasma contaminations were specifically tested using the Venor®GeM 
Mycoplasma detection kit according to manufacturer’s instructions. Briefly, the 
possible mycoplasma contamination was detected by amplifying the highly conserved 
16S rRNA coding region that generate an amplicon of approximately 267 bp. Internal 
DNA control of 191 bp was present in each sample, in order to confirm a successfully 
performed polymerase chain reaction (PCR). After PCR (Mastercycler; Eppendorf s.r.l.; 
Milan, IT), a 1.5% agarose gel in a Tris/acetic/ EDTA buffer (40 mMTris, 20 mM acetic 
acid and 1 mM EDTA) including ethidium bromide, as DNA staining, was cast and 10 μL 
of each PCR reaction, mixed with 2 μL of Blue/Orange 6X loading dye were loaded for 
electrophoresis (Peqlab Biotechnologie GmbH; Erlangen, DE); a 100 bp DNA ladder was 
used. At the end of the electrophoresis, gel were observed by a UV transilluminator 
(UVITEC; Cambridge, UK) and photographed. 
The presence of endotoxins on suspension supernatants was tested by using the Limulus 
Amebocyte Lysate (LAL) Kinetic-turbidimetric method (Charles River Endosafe; 
Charleston, SC, USA). This analysis was conducted in a 96-well plate and consisted in 
optical density (λ = 340 nm) measurements over time with the microplate reader 
(Synergy4, Bio-Tek Instruments Inc.; Winooski, VT, USA). The assay included a 
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standard curve of Escherichia coli endotoxin (from 5 to 0.005 EU/mL) and different 
dilutions of supernatants with and without standard in order to evaluate possible 
interferences. In particular, the onset time, which means the time required for the 
absorbance to increase significantly over the background (0.05 OD units), was calculated 
and a linear relation between standard endotoxin concentrations and onset time was 
established in order to calculate sample endotoxin concentrations. 
3.2.3 Morphological characterization 
Morphological analyses were performed with two different techniques. In particular, 
CoNPs were suspended in sterile water at the concentration of 1 mg/mL, ultrasonicated 
(Misonix S-4000 Ultrasonic Liquid Processors, Qsonica LLC.; Newtown, CT, USA) for 4 
minutes at 50% of amplitude (corresponding to 28000 J). This suspension was diluted in 
water at the concentration of 100 μg/mL to be examined by Transmission Electron 
Microscopy (TEM; FEI Tecnai 12 G2 electron microscope, FEI Co.; Eindhoven, NL) with 
Twin lens configuration after deposition on carbon coated, mesh 400 copper grids and 
left to dry. Micrographs were recorded on a side-mounted Morada CCD (Olympus Soft 
imaging Solutions GmbH, Münster, Germany) at magnifications ranging from 42000× 
to 265000×. To evaluate the aggregation state of NPs in suspension, dilution at the 
concentration of 10 μg/mL in cell culture complete media and water were done to be 
analyzed with the ZetasizerNano ZS Dynamic Light Scattering (DLS; Malvern 
Instruments; Malvern, UK). A blank (only cell culture media) sample were analyzed too. 
For the DLS analysis, suspensions were equilibrate at 25°C for 3 minutes and five 
measurements for sample were performed.  
3.2.4 CoNP dissolution 
CoNP suspensions in cell culture media were analyzed for ion release under our 
experimental conditions. In particular, different suspensions of CoNPs in cell culture 
media (0, 10, 100 and 1000 μg/mL) were prepared as in all the other analyses) were 
prepared from a stock suspension (10 mg/mL) that was ultrasonicated for 4 minutes at 
50% of amplitude (corresponding to 28000 J). Each suspension was incubated at 37°C, 
5% CO2 and 90% of humidity for 0, 6, 24 and 48 h in 24-well plates (1 mL for each well). 
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At the end of incubation NPs were removed from suspensions by collecting samples in 
2 mL tubes, centrifuging twice at 16000 g for 10 minutes and finally ultracentrifunging 
(OptimaTM L-100XP Ultracentrifuge; Beckman Coulter; Urbana, IL, USA) for 2 hours at 
300000 g at 4°C. Ultracentrifugation was conducted in polycarbonate tubes (Beckman 
Coulter; Urbana, IL, USA) with the rotor type 70.1.Ti (Beckman Coulter). Supernatants 
were collected and diluted with a 2% HNO3 solution prior to being analyzed for ion 
quantification with ICP-MS (NexION 300D, Perkin Elmer; Waltham, MA, 
USA).Simultaneously, 100 μg/mL solutions of Co2+in cell culture media and ddH2O were 
analyzed to monitor the ion behavior during the experiment. In addition, not 
ultracentrifuged NP suspensions and ion solutions were quantitatively analyzed by 
ICP-MS. In particular, ion solutions were simply diluted in 2% HNO3 solution in the 
calibration curve concentration range, whereas, NP suspensions were solubilized by 
microwave acid digestion (Mars V,CEM). 500 μL of each suspension were transferred in 
specific Teflon vessels and 10 mL of HNO3 (67-69% SpA) were added. Blank samples were 
included to the analysis to detect possible environmental contaminations. Microwave 
digestion program has foreseen two different steps: 1) increase of temperature until 
175°C in 7 minutes and 2) maintaining of 175°C for 3 minutes to complete digestion. After 
this acid digestion, solutions were diluted with ultrapure water (18,3 MΩ·cm-1) and 
analyzed by ICP-MS (NexION 300D, Perkin Elmer; Waltham, MA, USA). ICP-MS 
quantitative analyses of ionic release and NP and ion solution were performed using an 
external calibration curve. To limit signal drift, a rhodium solution (10 μg/L) as internal 
standard was added online to each standard and sample solutions.  
Furthermore, the effect of sonication on ion release was investigated. In particular, two 
stock suspensions of CoNPs were prepared in sterile H2O at the concentration of 10 
mg/mL. The first stock was ultrasonicated, while the second vortexed for 1 minute. Two 
different analysis were performed by ICP-MS (as described above): i) total Co 
concentration after digestion; ii) Co quantification after removal of NPs from stock 
suspension by ultracentrifugation; iii) soluble Co concentration after dilution of 
aqueous suspension in EMEM (1 mg/mL) and removal of NPs by ultracentrifugation. 
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3.3 Cell viability analyses 
3.3.1 Cell culture and sub-culturing procedure 
A549, L929 and HepG2 cells were maintained following ATCC indications. A549 cells 
were cultured in Ham’s F12K medium with the addition of 10 % FBS, 100 units/mL 
streptomycin and 100 μg/mL penicillin. HepG2 and L929 cells were cultured in EMEM 
with the addition of 10%FBS, 100 units/mL streptomycin and 100 μg/mL penicillin and 
2mM L-glutamine. All the three cell lines were kept at 37°C, 5% CO2 and 90% of 
humidity for maintenance and for experiments.  
3.3.2 CoNP and Co2+ toxicity 
In order to evaluate the cytotoxic effects of CoNPs and Co2+, cells were seeded in 96-well 
microplate and, 24 h after seeding, treated with different concentrations of NP and ions 
for 6, 24 and 48 h. The seeding densities of cells were those at which cells proliferated 
overtime: 5000 cell/well for A549 and L929 cells, and 15000 cell/well for HepG2 cells. 
Treatment solutions or suspensions were freshly prepared before each test. In 
particular, NPs were suspended in sterile water and ultrasonicated for 4 minutes at 50% 
of amplitude (corresponding to 28000 J) in order to make a stock suspension that was 
diluted in the proper cell culture media without exceeding the 10% of the total volume 
of the treatment. Ion stock solutions were prepared in ddH2O, filtered with 0.22 μm pore 
size filter and diluted in cell culture media as NP stock suspensions. Experiments were 
performed in triplicate. Viability was assessed after the removal of cell culture media 
and washing of cells with DPBS in order to eliminate possible NP interferences (Kroll et 
al., 2012). The two assays used were: MTS assay and ATP assay were performed 
according to manufacturer’s instructions. The MTS assay analyzes the conversion of a 
tetraziolium salt 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H] (MTS) into its reduced and soluble formazan form by mitochondrial 
enzyme of metabolically active cells and was evaluated by recording absorbance at 490 
nm. ATP assay is based on light production caused by the reaction of ATP with added 
luciferase and D-luciferin and quantify the ATP content. Both absorbance and 
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luminescence were recorded with the Synergy4 microplate reader (Bio-Tek 
Instruments). 
3.3.3 Vitamin B12 toxicity 
Vitamin B12 (Vit B12) was tested on all the three cell models with the ATP assay (following 
the same experimental procedure used for CoNPs and Co2+). Briefly, cells were treated 
with different concentration of Vit B12 for 6, 24 and 48 h. At the end of treatment, cells 
were washed twice with DPBS and ATP assay was performed following manufacturer’s 
instructions.  
3.3.4 Late effects 
Possible late effects induced by of CoNPs and Co2+ exposure were analyzed by 
incubating cells with each cobalt compound for 6 h, removing treatments and replacing 
with fresh culture media, after washing cells twice with DPBS, and finally analyzing 
ATP content at 24 and 48 h post treatment.  
3.4 Cellular uptake 
Cellular uptake of CoNPs and Co2+ was quantitatively analyzed by ICP-MS (NexION 
300D, Perkin Elmer). Cells were seeded in 24-well plate at densities 10 times higher 
compared to those used in 96-well plate experiments. After 24 h from seeding, cells were 
treated with 10 μg/mL of CoNPs or Co2+ for 24 h from stock suspensions prepared 
similarly to cytotoxicity tests. At the end of exposure time, cells were washed three-
times with PBS to remove NPs and ions not internalized. Cells were then detached with 
200 μL of Trypsin-EDTA and collected with 800 μL of PBS to be analyzed for protein 
quantification and uptake. Samples dedicated to protein quantification were 
centrifuged at 16000 g for 5 minutes. Then, supernatants were discarded and cell pellets 
were lysed with a lysis solution containing PBS 1X, 1% Triton X-100 and 1% SDS. Protein 
quantification was conducted using the microBCA assay. Bovine Serum Albumin (BSA) 
provided by the kit was diluted to prepare different standards in the linear 
concentration range of 10-40 μg/mL and manufacturer’s instructions were followed. To 
analyze uptake, samples were centrifuged at 400 g for 15 minutes. Once supernatants 
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were discarded pellets were digested with 1mL of HNO3. After an overnight incubation 
at room temperature, samples were incubated 12 h at 70°C in Thermoblock (FALC 
Instruments; Treviglio, IT) and finally diluted in ultrapure H2O (18,3 MΩ·cm-1). The 
obtained solutions were quantitatively analyzed by ICP-MS (NexION 300D, Perkin 
Elmer; Waltham, MA, USA) by using Dynamic Reaction Cell (DRC) method with a 
standard calibration curve and a rhodium solution as internal standard. 
3.5 Statistical analyses 
Statistical analyses were performed using Origin Pro 8.0 software (OriginLab; 
Northampton, MA, USA). Considering fitting curve analyses, cytotoxicity results were 
fitted by sigmoid functions and EC50 values were calculated. Statistical significances 
were determined by ANOVA analysis (P value < 0.05).  
4 Results 
4.1 CoNP characterization 
CoNPs showed three main elemental contaminants: aluminum (Al), arsenic (As) and 
boron (B) (Table 1). With respect to biological contaminations, no microbiological 
contaminations were found, and the endotoxin levels were below 0.01 EU/mL 
(corresponding to levels found in sterile water).  
TABLE 1. Elemental contaminations of CoNPs. 
Element μg/g 
a
 ± SD %
 b
 ± SD
Al 1258 ± 493 0.13 ± 0.05
As 171 ± 18 0.02 ± 0.002
B 423 ± 91 0.042 ± 0.009
Concentration
 
a: dry weight 
b: % expressed as w/w (dry weight) 
SD: standard deviation (mean of three determinations). 
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From TEM images, CoNPs appeared heterogeneous in size, spheroidal in shape and with 
a crystalline structure (Fig. 1). A strong aggregation state hampered an accurate size 
determination, even with manual particle selection methods. The presence of 
aggregates was confirmed by analyzing CoNP suspensions with DLS, as indicated by the 
high polidispersity index and the presence of very large objects. In the presence of cell 
culture media, smaller aggregates compared to water suspensions were observed (Fig. 
2). 
 
FIGURE 1. TEM images of CoNPs at different instrumental magnification: 
A) 97000 ×; B) 310000 ×. 
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FIGURE 2. DLS size distribution performed in A) water (PdI = 0.472); B) Ham’s F-
12K medium (PdI = 0.563) and C) EMEM (PdI = 0.448).  
4.2 CoNP dissolution 
Before performing dissolution studies of CoNPs by ultracentrifugation, the behavior of 
Co2+ in water and in EMEM and Ham’s F-12K culture media was studied. After 
ultracentrifugation, a significant reduction of Co2+ content was found in both cell 
culture media, while no differences were detected in aqueous solutions (Fig.3). However, 
no changes in Co2+ content after ultracentrifugation were observed over time, 
suggesting that no precipitation occurred under our experimental conditions (Fig. 4). 
Dissolution experiments of CoNPs showed that Co2+ is released in a dose- and time-
dependent manner (Fig. 5). Although the total amount of released Co increases as a 
function of CoNP concentration (Fig. 5A, 5B), the relative amount of soluble Co is higher 
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at low NP concentrations (Fig. 5C, 5D). No significant differences in CoNP behavior 
between the two media were observed. 
 
FIGURE 3. Analysis of concentrations of Co2+ before and after 
ultracentrifugation in water and cell culture media (Ham’s F-12K and EMEM). 
Data are expressed as mean of three different measurements, each of them 
expressed as % of stock solution concentrations. Error bars represent standard 
deviations of three different measurements. *Significant different from stock 
solution (P value < 0.05) 
 
FIGURE 4. Co2+ in solutions in water and cell culture media (Ham’s F-12K and 
EMEM) over time. Data are expressed as means of three measurements and 
error bars represents standard deviations. 
Interestingly, high ionic concentration was found at the starting time (0 h). To verify the 
role of sonication in inducing CoNP dissolution, Co content in both sonicated and no-
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sonicated NP stock suspensions was determined. No significant differences in ion 
release with or without sonication were found. Indeed, by analyzing the supernatant of 
the 10 mg/mL CoNP aqueous suspension, 1.4 ppm of Co2+ in the no-sonicated sample 
and 1.2 ppm in the sonicated one were measured, suggesting that in our experimental 
conditions sonication does not affect dissolution. Interestingly, the analysis of Co 
soluble fraction in cell culture media (obtained by dilution of the two stock suspensions) 
revealed higher amount (about 10%) compared to those obtained in aqueous stock 
suspensions (about 0.1%). 
  
  
FIGURE 5. Ions released by CoNPs in Ham’s F-12K (A, C) and EMEM (B, D) media 
overtime. Ion concentrations are reported as ppm (A, B) and % of stock 
suspension (C, D). Data are expressed as means of three measurements and 
error bars represents standard deviations. 
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4.3 CoNP and Co2+ toxicity 
Cell viability after treatment with CoNPs and Co2+ for 6, 24 and 48 h was evaluated by 
performing two different assays (ATP and MTS). For each exposure time, dose-response 
curves were fitted (Fig. 6, 7, 8) and EC50 values calculated (Table 2). ATP and MTS assays 
showed a dose-dependent effects of CoNPs and Co2+ in all the three in vitro models (Fig. 
6, 7, 8). Moreover, EC50 values obtained from dose-response curve showed also a time 
dependency of toxicity (Table 2). Although the impact on cell viability of CoNPs and Co2+ 
ions depended on the in vitro model used, dose-response  
curves and the relative EC50 values indicated a similar toxic effect for both CoNPs and 
Co2+ ions for each cell model. Major differences were observed at 6 h exposure time, 
while for longer exposure (24 and 48 h) the effects on cell viability were comparable 
between NPs and ions. 
The in vitro cell models showed different susceptibility to both CoNP and Co2+ ions with 
the following ranking: A549 > L929 > HepG2 (Table 2).  
TABLE 2. EC50 values of CoNPs and Co2+ in the three cell models at 6, 24 and 48 h. 
6 h 24 h 48 h 6 h 24 h 48 h 6 h 24 h 48 h
CoNP 81.8 27.6 3.4 181.8 39.4 12.9 202.2 70.7 6.9
Co2+ 19.3 17.8 11.3 183 28.1 12.2 220.9 43 12.3
CoNP 237.3 26.6 19.6 113.3 34.5 13.3 169.8 75 40.8
Co2+ 133.8 49.6 21.6 81.7 34.2 11.3 291.3 64.9 25.1
MTS assay
EC50 (μg/mL)
Compound
A549 L929 HepG2
ATP assay
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FIGURE 6. Dose-response curves obtained by treating A549 cells with CoNPs 
and Co2+ for 6 (A, D), 24 (B, E) and 48h (C, F). Panels A, B, C refer to ATP assay, 
while panels D, E, F refer to MTS assay. Data are expressed as mean of three 
independent experiments and error bars represent standard deviations. 
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FIGURE 7. Dose-response curves obtained by treating L929 cells with CoNPs and 
Co2+ for 6 (A, D), 24 (B, E) and 48h (C, F). Panels A, B, C refer to ATP assay, while 
panels D, E, F refer to MTS assay. Data are expressed as mean of three 
independent experiments and error bars represent standard deviations. 
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FIGURE 8. Dose-response curves obtained by treating HepG2 cells with CoNPs 
and Co2+ for 6 (A, D), 24 (B, E) and 48h (C, F). Panels A, B, C refer to ATP assay, 
while panels D, E, F refer to MTS assay. Data are expressed as mean of three 
independent experiments and error bars represent standard deviations. 
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4.4 Vitamin B12 toxicity 
Vit B12 is the only physiological form for cobalt. Therefore, its impact of physiological 
cobalt on cell viability in the same concentration range used for CoNP and Co2+ was also 
studied. As shown in Fig. 9, Vit B12 does not affect cell viability. Since Vit B12 is the well-
known physiological form of cobalt, our findings confirmed that biological systems are 
able to use essential elements only in their physiological forms. 
 
FIGURE 9. Vitamin B12 toxicity on A549 (A), L929 (B) and HepG2 (C) cells at 
different exposure time (6, 24, 48 h) evaluated by ATP assay. Data are expressed 
as mean of three independent experiments and error bars represent standard 
deviations.  
4.5 Late effects 
Late effects on cell viability after short-time exposure to CoNP and Co2+ ions were 
evaluated. Cells were treated with CoNP and Co2+ for 6 h, and their viability measured 
after 24 and 48 h after the removal of treatments. Dose-response curves for Co2+ and 
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CoNPs were time-dependent and showed a reduced toxicity than those obtained after 
long incubation times (Fig. 10, 11). Furthermore, CoNP toxicity resulted time-dependent 
if maximum effects were considered, whereas EC50 values did not change between 24 
and 48 h (Table 3). On the other hand, Co2+ time-dependent toxicity can be observed by 
considering both maximum effects and EC50 values (Table 3). 
 
TABLE 3. Maximum effect and EC50 values of L929 and HepG2 cells after 
6 h of exposure with Co compound and 24 and 48 h of recovery. 
24 h 48 h 24 h 48 h
CoNP 15.4 5.7 71.9 25.8
Co
2+ 0 0 11.9 0
CoNP 20.7 26.9 11.3 14.8
Co
2+ 101.6 75.5 N.D. 72.2
Compound
L929 HepG2
Max effect (% control)
EC50 (μg/mL)
 
N.D: not determined 
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FIGURE 10. CoNP (A, B) and Co2+ (C, D) toxicity on L929 cells measured by ATP 
assays after the removal of treatments (6 h post treatments). ATP assay were 
performed after 24 h (A, C) and 48 h (B, D) from treatment. Dose-response 
curves obtained by treating cells with CoNP and Co2+for 6, 24 and 48 h were 
also reported. Data are expressed as mean of three independent experiments 
and error bars represent standard deviations. 
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FIGURE 11. CoNP (A, B) and Co2+ (C, D) toxicity on HepG2 cells measured by ATP 
assays after the removal of treatments (6 h post treatments). ATP assays were 
performed after 24 h (A, C) and 48 h (B, D) from treatment. Dose-response 
curves obtained by treating cells with CoNP and Co2+ for 6, 24 and 48 h were 
also reported. Data are expressed as means of three independent experiments 
and error bars represent standard deviation. 
4.6 Cellular uptake 
Uptake experiments, concerning exposure of cells for 24 h with CoNPs and Co2+ ions, 
showed intracellular concentration of cobalt significantly higher with NP exposure 
compared to ionic treatments (Fig. 12). This suggest a more efficiently internalization of 
the cobalt in the form of particles than its ionic form (Fig. 12). In addition, intracellular 
cobalt concentrations were significantly different in the three in vitro models, with 
L929 cells showing higher cobalt content that A549 and HepG2 cells (P < 0.05). 
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FIGURE 12. Uptake of CoNPs and Co2+in A549, L929 and HepG2 cells. Data are 
expressed as ng of Co for μg/mL of proteins and error bars are standard 
deviations. ***Under detection limit (0.47μg/mL). 
5 Discussion 
Uncoated CoNPs appear strongly aggregated, though in cell culture media aggregates 
are smaller than in aqueous suspension. This is probably due to the interaction of NP 
with serum proteins as already observed with other metallic NPs (Murdock et al., 2008). 
CoNPs release ions in a time- and concentration-dependent fashion, as observed in 
other studies (Ponti et al., 2009; Jiang et al., 2012; Sabbioni et al., 2014b). Moreover, we 
confirmed a higher dissolution rate at lower CoNP concentrations (Sabbioni et al., 2014). 
This could be due to the presence of larger aggregates and lower surface-to-volume 
ratios at high CoNP concentrations (Misra et al., 2012; Gliga et al., 2014). Cell culture 
media favors ion release from CoNP surface because of the presence of Co sequestering 
agents, such as albumin and histidine, that shift the equilibrium toward free ions 
(Sabbioni et al., 2014b).  
CoNPs and Co2+ induce a time- and dose-dependent toxicity in all the three in vitro 
models. After 6 h exposure, CoNP are less toxic than Co2+ ions, while after 24 and 48 h 
incubation CoNP and Co2+ ions show similar effects on cell viability, in agreement with 
their time-dependent dissolution. Their similar toxicity has been reported in the 
literature, though these studies carried out in other in vitro models showed a higher 
toxicity of CoNPs compared to Co2+ for shorter exposure time, in apparent contrast with 
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our findings (Ponti et al., 2009; Jiang et al., 2012; Sabbioni et al., 2014a). The removal of 
treatment after 6 h, and the evaluation of cell viability after 24 and 48 h recovery, shows 
that CoNP and Co2+ toxicity is reduced but maintains time-dependency. With particular 
reference to CoNPs, we can speculate that their toxicity is closely related to dissolution 
occurring in cell culture media or inside cells. Indeed, the removal of NPs after 6 h, so 
limiting extracellular ions, causes a time-dependent toxicity at 24 and 48 h in agreement 
with their intracellular time-dependent dissolution. It has been also analyzed the 
toxicity of the only physiological form of cobalt, Vit B12. Despite the high concentration 
(considering that human nutritional requirement is 4 μg for adults), Vit B12 does not 
induce any adverse effect, in agreement with its physiological role (Seetharam and 
Alpers, 1982). This finding confirmed the crucial role of the chemical form in relation to 
the biological effects of elements in biological systems, as they can use and manage trace 
elements, including cobalt, only in defined chemical form, being other chemical species 
able to induce toxic effects (Bresson et al., 2013). 
Cell uptake studies showed the presence of significant amount of cobalt in cells exposed 
to CoNP compared to cells exposed to ions. However, in the present study, the cobalt 
internalization was determined as total cobalt and we could not establish whether its 
chemical form inside cells, such as particle, ion or both. In any case, our results agree 
with previous observation on another cell model (fibroblasts Balb/3T3 cells), in which 
considerable cobalt concentration were reached in cell organelles after CoNP exposure 
(Sabbioni et al., 2014b). Interestingly, we have found differences in the extent of cobalt 
internalization in the three in vitro cell models. The murine fibroblast L929 cells show 
higher CoNP internalization than A549 (lung epithelial cells) and HepG2 (hepatocytes) 
cells. However, the different cell susceptibility seems not related to differences in 
internalized Co concentration. Indeed, despite their similar uptake, A549 are the most 
susceptible cell models, while HepG2 cells result to be less affected by Co. 
To conclude, CoNPs toxicity is closely related to NP dissolution process occurring in cell 
culture medium and/or inside cells, as represented by Fig.13. 
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FIGURE 13. Possible mechanism of CoNP toxicity. Cell exposed to CoNPs can 
internalize CoNPs that release  Co2+ inside cells. On the other hand, the release 
of Co2+ can also occur in culture medium and free ions can be internalized 
through divalent metal transporter (DMT1) and calcium channel. Once inside 
cells, Co2+ leads to a decrease in cell viability ATP content and in mitochondrial 
metabolic activity. 
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Nickel nanoparticles: the dual toxicity mechanism 
1 Abstract 
In this study, the toxic effects of nickel nanoparticles (NiNPs) and their relative ions 
(Ni2+ ) were evaluated. Toxicity was analyzed in three different in vitro models: 
carcinomic human alveolar basal epithelial cell line (A549) and murine aneuploid 
fibrosarcoma cell line (L929) as in vitro models for inhalation and dermal contact, and 
human hepatocellular liver carcinoma cell line (HepG2) as a liver model. In addition, we 
studied NiNPs dissolution kinetics and nickel intracellular content after cell exposure. 
NiNPs resulted less toxic than Ni2+. NiNP dose-response relationship was characterized 
by a bimodal trend. In relation to the time- and dose-dependent NP dissolution, we 
hypothesized that he first transition was probably due to the NP itself and the second 
one to the released ions. In order to disclose these effects, NiNP cytotoxicity was 
evaluated in the presence of two different Ni2+ chelators: L-cysteine and L-histidine that 
show a strong affinity for this ion at the physiological pH range. In their presence, NiNP 
showed a unimodal dose-response curve with the maximum effect corresponding to the 
first transition obtained in the absence of nickel chelators. This finding confirms the role 
of dissolution and released ions in inducing the second transition. Finally, Ni 
internalization could partially explain differences in cell susceptibility, as A549 cells 
internalized more efficiently NiNPs than L929 and HepG2 cells and resulted more 
sensitive to the treatment. Overall, this study shows that NiNP toxicity is mediated by 
NPs themselves and nickel released ions in an independent manner. 
2 Introduction 
Nickel (Ni) is a transition metal of the d block (Cotton and Wilkinson, 1972). Its biological 
functions are very limited and confined to some dihydrogen reactions in symbiotic 
anaerobic bacteria and to urease in some plants and animals where Ni acts to keep 
ammonia balance (Da Silva and Williams, 2001). Ni in nanoparticulate form can find 
multiple industrial applications, including catalysts, sensors and energy storage device 
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in relation to their unique properties, which include high level of surface energy, high 
magnetism, low melting and burning points and high surface area (Ahamed, 2011; 
Pietruska et al., 2011; Magaye and Zhao, 2012). Ni-containing NPs were found to be more 
toxic than fine particles (Zhao et al., 2009). As for metal-based NPs, oxidative stress is 
involved in nickel NPs (Kang et al., 2003; Ahamed, 2011; Magaye and Zhao, 2012). 
Independently from the chemical form, such as metallic (NiNP), NiO or Ni3Si2, many 
studies suggest that Ni-containing NPs elicit their effects by means of Ni2+ (Griffitt et al., 
2008; Pietruska et al., 2011; Muñoz and Costa, 2012). For example, Pietruska et al. (2011) 
have found that both NiNPs and NiONPs caused the activation of HIF-1α signaling 
pathway in human epithelial cells, just as Ni2+. However, ion released from Ni-based 
NPs generally cannot fully explain the induced toxicity (Griffitt et al., 2008; Ispas et al., 
2009).  
This research was conducted to better understand NiNP toxicity. In particular, NiNP and 
Ni2+ toxicity were compared by performing two common viability assays (MTS and ATP 
assays) in three in vitro models: A549 (epithelial cells from human lung carcinoma) as 
in vitro model for inhalation exposure; L929 (fibroblast cells from murine subcutaneous 
connective tissue) as model of dermal contact exposure; and HepG2 (epithelial cells from 
human hepatocellular carcinoma) as liver model. In addition, the late effects following 
a short-time exposure with NiNP and Ni2+ were evaluated. The contribution of ion 
release in NiNP toxicity was studied by analyzing dissolution kinetics in cell culture 
media, and using two Ni2+ chelators during NiNP cell treatment. Toxicological data were 
related to internalized Ni2+ and NiNP for explaining observed differences in toxicity 
among cell lines. 
3 Materials and Methods 
3.1 Chemicals and reagents 
Metallic NiNPs (Product Code:NI-M-03M-NP.020N) were purchased in dry form from 
American Elements® (Merelex Corporation, Los Angeles, CA, USA). They had the 
following properties as indicated by the supplier: average diameter of 20 nm (with size 
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range from 2 to 50 nm), specific area of 40-60 m2/g and spherical shape. Acid solution 
of HNO3 (67-69% SpA) and HCl (33-36% UpA) were purchased from Romil (Cambridge, 
UK). Reagents for biological characterization were: Tryptic Soy Agar (TSA; Biolife 
Italiana S.r.l.; Milan, IT); Venor®GeM Mycoplasma detection kit (Minerva Biolabs, 
Berlin, De), GoTaq® DNA polymerase, 5X Colorless GoTaq® Reaction Buffer, 
Blue/Orange 6X loading dye, 100 bp DNA ladder (Promega; Madison, WI, USA); all 
reagents for the detection of endotoxin were purchased from Charles River Laboratories 
International, Inc (Charleston, SC, USA). NiCl2·6H2O (Product Code: N6136), L-cysteine 
(Product Code:W326305), L-histidine (Product Code: 53319), Triton X-100 and agarose 
were purchased from Sigma–Aldrich (Gillingham, UK). Sodium Dodecyl Sulphate (SDS), 
staurosporine (STS), Trizma® base primary standard and buffer, 
ethylenediaminetetraacetic acid disodium salt dehydrate (EDTA), acetic acid (puriss., 
99-100%), ethidium bromide solution (10 mg/mL in H2O) and Phosphate Buffer Saline 
(PBS) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Cytotoxicity was tested 
with CellTiter 96 AQueous Non-Radioactive Cell Proliferation Assay kit Promega 
(Madison, WI, USA) and ATPlite (Perkin Elmer, Waltham, MA, USA). Human lung 
carcinoma epithelial cells (A549), murine subcutaneous connective tissue fibroblast 
cells (L929) and human hepatocellular carcinoma epithelial cells (HepG2) were obtained 
from American Type Culture Collection (Manassas, VA, USA). Solution for cell culture 
were: Ham’s F-12K and Eagle Minimum Essential Medium (EMEM), fetal bovine serum 
(FBS), penicillin-streptomycin solution, L-glutamine, phosphate buffered saline (PBS), 
Dulbecco’s phosphate buffered saline with calcium and magnesium (DPBS), Trypsin-
EDTA, all purchased from Lonza (Basel, CH). Protein quantification was conducted by 
using MicroBCATM Protein Assay Kit (Thermo Scientific; Rockford, IL, USA).  
3.2 NiNP characterization 
NiNPs were characterized for chemical and biological contaminations, and 
morphological properties.  
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3.2.1 Chemical characterization 
To detect chemical impurities in NiNPs, a semi-quantitative analysis (ranging from 6 to 
240 amu) by inductively coupled plasma mass spectrometry (ICP-MS; NexION 300D, 
Perkin Elmer Inc.; Waltham, MA, USA) was conducted. In particular, dry NPs were 
solubilized with a microwave assisted acid digestion. Briefly, NPs were weighted in 
specific Teflon vessels and suspended with 75% HNO3 (67-69% SpA) and 25% HCl (33-
36% UpA). In order to detect possible environmental contaminations blank samples 
were included in the analysis. Microwave digestion was performed by using a Mars V 
microwave (CEM Corporation; Matthews, NC, USA) and the program used has foreseen 
two different steps: i) increase of temperature until 175°C in 5.5 minutes and ii) 
maintaining of 175°C for 4.5 minutes to complete digestion. After this acid digestion, 
solutions were diluted with ultrapure water (18,3 MΩ·cm-1) and analyzed by means of 
ICP-MS with a semi-quantitative method. The most concentrated elements detected 
were quantified by using an external calibration curve. To limit signal drift, a rhodium 
solution (10 μg/L) as internal standard was added online to each standard and sample 
solutions.  
3.2.2 Biological contaminations 
In order to avoid microbiological contaminations that could influence cellular 
responses during experiments, microbiological contaminations and endotoxin 
presence were tested on CoNPs suspensions. In particular, NPs were suspended at the 
concentration of 1 mg/mL in sterile water and ultrasonicated for 4 minutes at 50% of 
amplitude, corresponding to 28000 J (Misonix S-4000 Ultrasonic Liquid Processors, 
Qsonica LLC.; Newtown, CT, USA). To detect possible generic fungal and bacterial 
contaminations, 100 μL of the suspensions were plated in TSA plates and incubated at 
37°C for 72 h. After the incubation, the presence of colonies on the plates was verified. 
In addition, mycoplasma contaminations were specifically tested using the Venor®GeM 
Mycoplasma detection kit according to manufacturer’s instructions. Briefly, the 
possible mycoplasma contamination was detected by amplifying the highly conserved 
16S rRNA coding region that generate an amplicon of approximately 267 bp. Internal 
DNA control of 191 bp was present in each sample, in order to confirm a successfully 
CHAPTER 3 
94 
 
performed polymerase chain reaction (PCR). After PCR (Mastercycler; Eppendorf s.r.l.; 
Milan, IT), a 1.5% agarose gel in a Tris/acetic/ EDTA buffer (4 μmMTris, 20 mM acetic 
acid and 1 mM EDTA) including ethidium bromide, as DNA staining, was cast and 10 μL 
of each PCR reaction, mixed with 2μL of Blue/Orange 6X loading dye were loaded for 
electrophoresis (Peqlab Biotechnologie GmbH; Erlangen, DE); a 100 bp DNA ladder was 
used. At the end of the electrophoresis, gel were observed by a UV transilluminator 
(UVITEC; Cambridge, UK) and photographed. 
The presence of endotoxins on suspension supernatants was tested by using the Limulus 
Amebocyte Lysate (LAL) Kinetic-turbidimetric method (Charles River Endosafe; 
Charleston, SC, USA). This analysis was conducted in a 96-well plate and consisted in 
optical density (λ = 34μnm) measurements over time with the microplate reader 
(Synergy4, Bio-Tek Instruments Inc.; Winooski, VT, USA). The assay included a 
standard curve of Escherichia coli endotoxin (from 5 to 0.005 EU/mL) and different 
dilutions of supernatants with and without standard in order to evaluate possible 
interferences. In particular, the onset time, which means the time required for the 
absorbance to increase significantly over the background (0.05 OD units), was calculated 
and a linear relation between standard endotoxin concentrations and onset time was 
established in order to calculate sample endotoxin concentrations. 
3.2.3 Morphological characterization 
Morphological analyses were performed with two different techniques. In particular, 
CoNPs were suspended in sterile water at the concentration of 1 mg/mL, ultrasonicated 
(Misonix S-4000 Ultrasonic Liquid Processors, Qsonica LLC.; Newtown, CT, USA) for 4 
minutes at 50% of amplitude (corresponding to 28000J). This suspension was diluted in 
water at the concentration of 100 μg/mL to be examined by Transmission Electron 
Microscopy (TEM; FEI Tecnai 12 G2 electron microscope, FEI Co.; Eindhoven, NL) with 
Twin lens configuration after deposition on carbon coated, mesh 400 copper grids and 
left to dry. Micrographs were recorded on a side-mounted Morada CCD (Olympus Soft 
imaging Solutions GmbH, Münster, Germany) at magnifications ranging from 42000× 
to 265000×. To evaluate the aggregation state of NPs in suspension, dilution at the 
concentration of 10 μg/mL in cell culture complete media and water were done to be 
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analyzed with the ZetasizerNano ZS Dynamic Light Scattering (DLS; Malvern 
Instruments; Malvern, UK). A blank (only cell culture media) sample were analyzed too. 
For the DLS analysis, suspensions were equilibrate at 25°C for 3 minutes and five 
measurements for sample were performed.  
3.3 NiNP dissolution 
NiNP suspensions in cell culture media were analyzed for ion release during 
experimental conditions. In particular, different concentrations (0, 50, 500 and 5000 
μg/mL) prepared as in all the other analyses) of NiNPs in cell culture media were 
prepared from a stock suspension (10 mg/mL) ultrasonicated for 4 minutes at 50% of 
amplitude (corresponding to 28000 J). Each suspension was incubated at 37°C, 5% 
CO2and 90% of humidity for 0, 6, 24 and 48 h in 24-well plates (1 mL for each well). At 
the end of incubation NPs were removed from suspensions by collecting samples in 2 
mL tubes, centrifuging twice at 16000 g for 10 minutes and finally ultracentrifuging 
(OptimaTM L-100XP Ultracentrifuge; Beckman Coulter; Urbana, IL, USA) for 2 hours at 
300000 g at 4°C. Ultracentrifugation was conducted in polycarbonate tubes (Beckman 
Coulter; Urbana, IL, USA) with the rotor type 70.1.Ti (Beckman Coulter). Supernatants 
were collected and diluted with a 2% HNO3 solution prior to being analyzed for ion 
quantification with ICP-MS (NexION 300D, Perkin Elmer; Waltham, MA, 
USA).Simultaneously, 100 μg/mL solutions of Ni2+in cell culture media and ddH2O were 
analyzed to monitor the ion behavior during the experiment. In addition, not 
ultracentrifuged NP suspensions and ion solutions were quantitatively analyzed by 
ICP-MS. In particular, ion solutions were simply diluted in 2% HNO3 solution in the 
calibration curve concentration range, whereas, NP suspensions were solubilized by 
microwave acid digestion (Mars V,CEM). 500 μL of each suspension were transferred in 
specific Teflon vessels and 10 mL of HNO3 (67-69% SpA) were added. Blank samples were 
included to the analysis to detect possible environmental contaminations. Microwave 
digestion program has foreseen two different steps: 1) increase of temperature until 
175°C in 7 minutes and 2) maintaining of 175°C for 3 minutes to complete digestion. After 
this acid digestion, solutions were diluted with ultrapure water (18,3 MΩ·cm-1) and 
analyzed by ICP-MS (NexION 300D, Perkin Elmer; Waltham, MA, USA). ICP-MS 
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quantitative analyses of ionic release and NP and ion solution were performed using an 
external calibration curve. To limit signal drift, a rhodium solution (10 μg/L) as internal 
standard was added online to each standard and sample solutions.  
3.4 Cell viability analyses 
3.4.1 Cell culture and sub-culturing procedure 
A549, L929 and HepG2 cells were maintained following ATCC indications. A549 cells 
were cultured in Ham’s F12K medium with the addition of 10 % FBS, 100 units/mL 
streptomycin and 100 μg/mL penicillin. HepG2 and L929 cells were cultured in EMEM 
with the addition of 10%FBS, 100 units/mL streptomycin and 100 μg/mL penicillin and 
2mM L-glutamine. All the three cell lines were kept at 37°C, 5% CO2 and 90% of 
humidity for maintenance and for experiments.  
3.4.2 NiNP and Ni2+ toxicity 
In order to evaluate the cytotoxic effects of NiNPs and Ni2+, cells were seeded in 96-well 
microplate and, 24h after seeding, treated with different concentrations of NPs and ions 
for 6, 24 and 48 h. The seeding densities of cells were those at which cells proliferated 
overtime: 5000 cell/well for A549 and L929 cells, and 15000 cell/well for HepG2 cells. 
Treatment solutions or suspensions were freshly prepared before each test. In 
particular, NPs were suspended in sterile water and ultrasonicated for 4 minutes at 50% 
of amplitude (corresponding at 28000 J) in order to make a stock suspension that was 
diluted in the proper cell culture media without exceeding the 10% of the total volume 
of the treatment. Ion stock solutions were prepared in ddH2O, filtered with 0.22 μm pore 
size filter and diluted in cell culture media as NP stock suspensions. Experiments were 
performed in triplicate. Viability was assessed after the removal of cell culture media 
and washing of cells with DPBS in order to eliminate possible NP interferences (Kroll et 
al., 2012). The two assays used were: MTS assay and ATP assay were performed 
according to manufacturer’s instructions. The MTS assay analyzes the conversion of a 
tetraziolium salt 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H] (MTS) into its reduced and soluble formazan form by mitochondrial 
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enzyme of metabolically active cells and was evaluated by recording absorbance at 490 
nm. ATP assay is based on light production caused by the reaction of ATP with added 
luciferase and D-luciferin and quantify the ATP content. Both absorbance and 
luminescence were recorded with the Synergy4 microplate reader (Bio-Tek 
Instruments). 
3.4.3 Analysis of the bimodal dose-response curves of NiNPs 
In order to discriminate the contribution of Ni ions in NiNP cytotoxicity, we performed 
the ATP content analysis on the three cell lines after a 24 h (A549 cells) or 48 h treatment 
(A549, L929 and HepG2 cells) with NiNP in presence of L-cysteine and L-histidine, as 
Ni2+chelating agents. In particular, cells were treated with different concentration of 
NiNPs and L-cysteine or L-histidine 6.8mM. This concentration is calculated on the 
basis of NiNP dissolution experiments and correspond to the twofold equimolar highest 
concentration of Ni2+found to be released at 48 h (Forgacs et al., 2001). 
3.4.4 Late effects 
Possible late effects induced by of NiNPs and Ni2+ exposure were analyzed by incubating 
cells with each nickel compound for 6 h, removing treatments and replacing with fresh 
culture media, after washing cells twice with DPBS, and finally analyzing ATP content 
at 24 and 48 h post treatment.  
3.5 Analysis of cellular uptake 
Cellular uptake of NiNPs and Ni2+ was quantitatively analyzed by ICP-MS (NexION 
300D, Perkin Elmer). Cells were seeded in 24-well plate at densities 10 times higher 
compared to those used in 96-well plate experiments. After 24 h from seeding, cells were 
treated for 24 h with 10 μg/mL of NiNPs or Ni2+ obtained from stock suspensions 
prepared similarly to cytotoxicity tests. At the end of exposure, cells were washed three-
times with PBS to remove NPs and ions not internalized. Cells were then detached with 
200 μL of Trypsin-EDTA and collected with 800 μL of PBS to be analyzed for protein 
quantification and uptake. Samples dedicated to protein quantification were 
centrifuged at 16000 g for 5 minutes. Then, supernatants were discarded and cell pellets 
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were lysed with a lysis solution containing PBS 1X, 1% Triton X-100 and 1% SDS. Protein 
quantification was conducted using the microBCA assay. Bovine Serum Albumin (BSA) 
provided by the kit was diluted to prepare different standards in the linear 
concentration range of 10-40 μg/mL and manufacturer’s instructions were followed. To 
analyze uptake, samples were centrifuged at 400 g for 15 minutes. Once supernatants 
were discarded pellets were digested with 1mL of HNO3. After an overnight incubation 
at room temperature, samples were incubated 12 h at 70°C in Thermoblock (FALC 
Instruments; Treviglio, IT) and finally diluted in ultrapure H2O (18,3 MΩ·cm-1). The 
obtained solutions were quantitatively analyzed by ICP-MS (NexION 300D, Perkin 
Elmer; Waltham, MA, USA) by using Dynamic Reaction Cell (DRC) method with a 
standard calibration curve and a rhodium solution as internal standard. 
3.6 Statistical analyses 
Statistical analyses were performed using Origin Pro 8.0 software (OriginLab; 
Northampton, MA, USA). Cytotoxicity results were fitted by sigmoid functions and 
EC50 values were calculated. Where bimodal dose-response curves appeared more 
appropriate, F-tests were performed to compare unimodal and bimodal models. 
Statistical significance was determined by ANOVA analysis (P value < 0.05).  
4 Results 
4.1 NiNP characterization 
Chemical purity analysis showed that NiNPs had three main chemical contaminations: 
cobalt (Co), copper (Cu) and germanium (Ge) (Table 1). 
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TABLE 1. Elemental contaminations of NiNPs.  
Element μg/g 
a
 ± SD %
 b
 ± SD
Co 19.4 ± 0.1 0.002 ± 0.000
Cu 25.1 ± 0.2 0.003 ± 0.000
Ge 3.3 ± 0.7 0.0000 ± 0.0000
Concentration
 
a: dry weight 
b: % expressed as w/w (dry weight)  
SD: standard deviation (mean of three determinations). 
NiNPs did not display microbiological contaminations and the endotoxin levels were 
below 0.01 EU/mL (corresponding to levels found in sterile water).  
 
FIGURE 1. TEM images of NiNPs at different instrumental magnifications: 
A) 57000 ×; B) 195000 ×. 
NiNPs appeared in a crystalline form, aggregated and mainly spheroidal in shape (Fig.1). 
No isolated, individual particles were found in the sample. Since the borders of 
individual particles could not be easily determined, a manual selection of apparent 
particle diameters was used for particle size distribution determination, resulting in a 
mean particle diameters of 22.7 ± 9.8 nm. However, size was found to range between 4.8 
and 71.9 nm (Fig. 2). 
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FIGURE 2. NiNP size-distribution. 
 
FIGURE 3. DLS size distribution performed in A) water (PdI = 0.279), B) Ham’s F-
12K medium (PdI = 0.765) and C) EMEM (PdI = 0.592).  
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DLS analysis of NiNP suspensions showed an aggregated and highly polydisperse 
system, as can be observed by Polidispersity Index (PdI) and by the presence of different 
peaks in DLS size distribution graphics (Fig. 3). 
4.2 NiNP dissolution 
Ultracentrifugation was performed to separate NiNPs from potentially released ions for 
determining NP dissolution rate under our experimental conditions. Before the 
analysis, the possible precipitation of Ni ions after ultracentrifugation was evaluated. In 
the presence of EMEM, a slight but significant decrease (about 20%) in nickel content 
was observed (Fig.4). However, no ion precipitation occurred over time (Fig. 5). 
 
FIGURE 4. Analysis of concentrations Ni2+ before and after ultracentrifugation 
in water and cell culture media. Data are expressed as mean of three different 
measurements, each of them expressed as % of stock solution concentrations. 
Error bars represent standard deviations of three different measurements. * 
Significant different from stock solution (P value < 0.05) 
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FIGURE 5. Ni2+ in solutions over time in water and cell culture media (Ham’s F-
12K and EMEM). Data are expressed as means of three measurements and error 
bars represents standard deviations. 
 
FIGURE 6. Ions released from NiNPs in Ham’s F-12K (A, C) and EMEM (B, D) 
media overtime. Data are expressed as mean of three measurements and error 
bars represents standard deviations. 
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The ion release from NiNPs appeared to be dependent on both time and NP 
concentration, whereas it was not related to the type of cell culture medium (Fig. 6). 
Although the total amount of released nickel is proportional to the amount of NiNPs in 
suspension (Fig. 6A, 6B), dissolution rate is higher at low NP concentration (Fig. 6C, 6D). 
4.3 NiNP and Ni2+ toxicity 
After exposure of the three cells models to NiNPs and Ni2+ ions, cell viability was 
evaluated by MTS and ATP assays and dose-response curves were fitted (Fig. 7, 8, 9) and 
EC50 values were calculated (Table 2). Both NiNPs and Ni2+showed a dose- and time-
dependent toxicity in all the in vitro models used (Fig. 7, 8, 9 and Table 2). Interestingly, 
NiNP dose-response curves displayed a bimodal trend in A549 and HepG2 cells, 
respectively at 24 h and 48 h or only at 48 h (Fig. 7, 9). Exposure of L929 cells produced 
unimodal dose-response curves in L929 (Fig. 8). The calculated EC50 values (Table 2) 
were different among the three cell models. In particular, when ATP assay was 
performed to assess toxic effects, the A549 cells were the most susceptible cells, followed 
by HepG2 and then L929 cells. Cell viability determined by MTS assay showed a 
different ranking in terms of susceptibility (L929 > A549 > HepG2). 
TABLE 2. EC50 values of NiNPs and Ni2+ in the three cell models at 6, 24 and 48 h. 
6 h 24 h 48 h 6 h 24 h 48 h 6 h 24 h 48 h
NiNP N.D. 3/1200* 2.8/161.7* N.D. 94.6 59 249.5 49.5 10.3/303.1*
Ni2+ N.E. 49.5 24.6 222.6 85.8 26.3 127.6 33.2 19.5
CoNP N.E. 44.6/2170* 6.3/641.5* N.D. 174.5 49.4 N.D. 917.3 11.4/349.9*
Ni2+ N.E. 122.9 33.7 258.4 82.2 12.3 N.D. 136.7 61.6
MTS assay
EC50 (μg/mL)
Compound
A549 L929 HepG2
ATP assay
 
N.E.: no effect. 
N.D.: not determined. 
* Double EC50 values calculated from bimodal dose-response curves. 
CHAPTER 3 
104 
 
 
FIGURE 7. Dose-response curves obtained by treating A549 cells with NiNPs and 
Ni2+ for 6 (A, D), 24 (B, E) and 48 h (C, F). Panels A, B, C refer to ATP assay, while 
panels D, E, F refer to MTS assay. Data are expressed as mean of three 
independent experiments and error bars represent standard deviations. 
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FIGURE 8. Dose-response curves obtained by treating L929 cells with NiNPs and 
Ni2+ for 6 (A, D), 24 (B, E) and 48 h (C, F). Panels A, B, C refer to ATP assay, while 
panels D, E, F refer to MTS assay. Data are expressed as mean of three 
independent experiments and error bars represent standard deviations. 
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FIGURE 9. Dose-response curves obtained by treating HepG2 cells with NiNPs 
and Ni2+ for 6 (A, D), 24 (B, E) and 48 h (C, F). Panels A, B, C refer to ATP assay, 
while panels D, E, F refer to MTS assay. Data are expressed as mean of three 
independent experiments and error bars represent standard deviations. 
4.4 Analysis of the bimodal NiNP dose-response curves 
In order to explain the bimodal trend of NiNP dose-response curves in A549 and HepG2, 
two chelators with high affinity for Ni2+ (L-cysteine (L-Cys) and L-histidine (L-His)) 
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were used to complex free Ni2+ released by NPs. In presence of L-Cys and L-His the 
second transition was prevented, and the maximum effect corresponded to the that ot 
the first plateau observed in the bimodal dose-response curves (Fig.10). Therefore, the 
observed bimodal trend would reflect the dual effect of NiNPs and the corresponding 
released ions. In L929 cells, for which no bimodal dose-response was observed, L-Cys 
and L-His only reduced NiNP toxicity (Fig. 10D) and the protective effect of L-Cys 
resulted more pronounced compared to L-His, as can be observed form EC50 values 
(Table 3). 
 
FIGURE 10. Toxicity of NiNPs in absence or presence of L-Cys or L-His assessed 
by ATP assay. A) Analysis on A549 after 24 h of treatment; B) Analysis on A549 
after 48 h of treatment; C) Analysis on HepG2 after 48 h of treatment and D) 
Analysis on L929 after 48 h. Data are expressed as means of three independent 
experiments and error bars represent standard deviation. 
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TABLE 3. EC50 values and maximum effects of A549, L929 and HepG2 cells 
treated with NiNPs and L-Cys or L-His.  
L929 HepG2
24 h 48 h 48 h 48 h
L-Cys 50.6 30.7 0 44.8
L-His 51.8 44.8 6.8 39.7
L-Cys 30.9 17 342 54.5
L-His 15.2 11.8 59.9 12.3
Chelator
A549
Max effect (% control)
EC50 (μg/mL)
 
N.D: not determined 
4.5 Late effects 
To investigate the effects of internalized NiNPs reducing extracellular ion release, a 
short time exposure experiment was performed. Cells were exposed to NiNP and Ni2+ 
for 6 h, and their viability measured after 24 and 48 h recovery. Short-time incubation 
with NiNPs induced a dose- and time-dependent impact on cells (Fig. 11A, 11B, 12A, 12B), 
though the maximum effect does not change over time (Table 4). Ni2+ toxicity resulted 
to be only slightly time-dependent in HepG2 cells (Fig. 12C, 12D), whereas in L929, 
where no dose-response curves were obtained, it appeared independent of time (Fig. 
11C, 11D). 
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TABLE 3. Maximum effect and EC50 values of L929 and HepG2 cells after 6 
h of exposure with Ni compound and 24 and 48 h of recovery. 
24 h 48 h 24 h 48 h
NiNP 42.2 40.8 17.3 32
Ni
2+ 0 0 37.6 20
NiNP 22.1 7.8 26 23
Ni
2+ N.D. N.D. 46.5 N.D.
Compound
L929 HepG2
Max effect (% control)
EC50 (μg/mL)
 
N.D: not determined  
 
FIGURE 11. NiNP (A, B) and Ni2+ (C, D) toxicity on L929 cells measured by ATP 
assays after the removal of treatments (6 h post treatments). ATP assay were 
performed after 24 h (A, C) and 48 h (B, D) from treatment. Dose-response 
curves obtained by treating cells with NiNPs and Ni2+ for 6, 24 and 48 h were 
also reported. Data are expressed as means of three independent experiments 
and error bars represent standard deviation. 
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FIGURE 12. NiNP (A, B) and Ni2+ (C, D) toxicity on HepG2 cells measured by ATP 
assays after the removal of treatments (6 h post treatments). ATP assay were 
performed after 24 h (A, C) and 48 h (B, D) from treatment. Dose- response 
curves obtained by treating cells with NiNPs and Ni2+ for 6, 24 and 48 h were 
also reported. Data are expressed as means of three independent experiments 
and error bars represent standard deviation. 
4.6 Cellular uptake 
To understand NP toxicity in in vitro studies the knowledge of the uptake is a 
fundamental aspect. With this respect, the quantification of NiNP and Ni2+ internalized 
by the three cell models was determined. A higher intracellular Ni concentration was 
found in NiNPs-treated cells than compared to the those treated with nickel ions (Fig. 
13). Furthermore, the cellular uptake of NiNP-treated cells were cell-type dependent; 
indeed. A549 cells showed the higher nickel concentration followed by L929 and HepG2 
(P < 0.05). 
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FIGURE 13. Uptake of NiNP and Ni2+in A549, L929 and HepG2 cells. Data are 
expressed as ng of Ni for protein concentrations and error bars are standard 
deviations. *** Under detection limit (0.47μg/mL). 
5 Discussion 
Size distribution analysis showed that NiNPs dimension is heterogeneous with a size 
range from 4.8 to 71.9 nm, i.e. in the nano-size range. NiNP tendency to aggregate does 
not depends on the medium since DLS measurements showed that aggregation is 
present both in water and cell culture media. As different authors suggested a role of 
ions released by NiNPs in inducing NP toxicity (Griffitt et al., 2008; Pietruska et al., 2011; 
Muñoz and Costa, 2012), we analyzed the release of soluble Ni. A time- and 
concentration-dependent NP dissolution rate was observed. Despite higher 
concentration of NPs results into a higher concentration of ions, the observed 
dissociation rate is higher in the presence of low NiNPs concentration. This observation 
could be related to the different aggregation states of NiNPs as a function of their 
concentration (Misra et al., 2012).  
In vitro viability assays show that NiNPs are less toxic than the corresponding ionic 
form. Dose-response curves obtained treating A549 and HepG2 cells with increasing 
NiNPs concentrations are characterized by a bimodal trend. The bimodal trend could 
indicate the presence of different mechanisms of action, of the superimposition of 
multiple effects or of a heterogeneity of the cellular population (i.e. the presence of 
different cell subpopulation in the assay) (Derelanko and Auletta, 2014). Considering the 
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kinetic of ion release (strongly related to the NP concentration) and the NiNP bimodal 
dose-response curves, we hypothesize that the first transition is probably due to the 
toxicity of NP itself while the second one is probably due to the released ions. In order 
to discriminate the specific contribution of the presence of ions from that of the NiNPs, 
a co-treatment of cells with both NiNPs and two Ni2+chelators (such as L-Cys and L-Hys) 
was performed. In the presence these two chelators, NiNPs showed a unimodal dose-
response curve with the maximum effect corresponding to the viability reduction of the 
first transition obtained in the absence of nickel chelators. Furthermore, L-Cys resulted 
to be more efficient than L-His in reducing NiNP toxicity, probably because of its 
antioxidant property; in fact, it has been demonstrated that ROS generation could be 
involved in NiNP toxicity (Morel and Barouki, 1999; Ahamed, 2011; Kang et al., 2011). 
Late effect experiments indicated that toxicity mediated by internalized NiNPs is not 
time-dependent. Taking into consideration dissolution kinetics, the time-
independency is compatible with a low amount of internalized NiNPs after 6 h of 
exposure and the reduced ion release in intracellular compartments.  
Cellular uptake of NiNPs and nickel ions indicated that NiNPs enter more readily into 
cells than Ni2+ ions in all the three cell models. This difference may be related to the 
different uptake mechanisms involved in internalization of the different forms of Ni. 
While NiNPs are internalized via endocytic mechanisms (Muñoz and Costa, 2012), Ni2+ 
uptake is associated to membrane transporters, such as DMT1 (divalent metal 
transporter 1) or calcium channel, competing with other physiological divalent cations, 
such as iron and calcium (Denkhaus and Salnikow, 2002). Moreover, the cell lines used 
in this work showed a different degree of Ni internalization following NiNP exposure. 
This could partially explain the degree of toxicity induced by NiNPs in the three cell 
models. A549 cells internalize more efficiently NiNPs than L929 and HepG2 cells and 
they are more sensitive to the treatment. Considering L929 cells, the unimodal trend of 
dose-response curves can be explained by the high NiNP toxicity that prevents the effect 
of release the ions. 
In conclusion, NiNP toxicity is mediated by NPs themselves and nickel released ions in 
an independent manner, as summarized in Fig.14. At low NiNP concentrations the effect 
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on viability depends only on NPs, whereas at high concentrations, NiNP toxicity is 
mainly due to the released Ni2+. 
 
FIGURE 14. Putative mechanism of NiNP toxicity. At low NiNP concentration, 
the amount of ions released into the culture media is limited, suggesting that 
the effect on cell viability (i.e. ATP content and mitochondrial metabolic 
activity) is related only to NP internalization and the release of Ni2+ inside cells. 
On the contrary, at high concentrations of NiNPs, there are higher levels of free 
Ni2+ released by NPs that could enter into the cells through the DMT1 (divalent 
metal transporter 1) or calcium channels. This induces a large toxic effect as 
described by the bimodal dose-response curve shown in the scheme. 
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The growing development of nanotechnology and the subsequent increasing use of NMs 
lead to an increase human and environmental exposure. Therefore, the safety 
evaluation of NM toxicity is needed. This work focuses on the toxicological effects of 
zerovalent FeNPs, CoNPs and NiNPs, whose three constituent elements belong to the 
main transition group and share ferromagnetic properties. In relation to the specific 
objectives of this study, the following conclusions can be drawn. 
I. Physico-chemical characterization of FeNPs, CoNPs, NiNPs. 
Fe-, Co- and NiNPs have similar nominal average diameters. TEM and DLS analysis 
indicated that all the metallic NPs aggregate in suspension, making difficult to relate 
their toxic effects to the primary size. Data on chemical and biological 
contaminations, revealed the absence of endotoxins and mycoplasma, suggesting 
that artifacts due to the presence of such contaminants can be reasonably excluded 
under our experimental conditions.  
II. Dissolution of NPs in culture media. 
NP dissolution was different and depending on the constituent element of the 
nanoparticles. No free Fe ions released by FeNPs were found, whereas CoNP and 
NiNP dissolution was dose- and time-dependent. However, CoNP suspensions 
showed higher ion concentrations compared to those of NiNPs. In relation to the 
high soluble Co content, our results would tend to exclude the effect of sonication on 
NP dissolution. 
III. In vitro toxicity induced by NPs on the three cell models. 
Toxic effects were observed in all case, i.e. when the three different NPs were used to 
treat each of the three cell line models used. However, in all the in vitro models NP 
toxicity degree was different: CoNPs were the most toxic, followed by NiNPs and 
FeNPs. The same toxicity ranking was observed also when the corresponding ions 
were considered; this rank is probably related to the physiological role of these 
elements. Although the similar NP toxicity ranking, the three different cell lines 
showed different susceptibility. In particular, lung epithelial cells (A549) were more 
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susceptible compared to dermal fibroblast (L929), the latter being more sensitive 
than hepatocytes (HepG2). A direct relation between toxicity and dissolution degree 
of NP was found. Furthermore, a peculiar bimodal trend in NiNP dose-response 
curves was observed. We demonstrated that this behaviour ensue from two 
simultaneous but independent mechanisms responsible for NiNP toxicity that 
involve both NPs themselves and Ni ions released from the particles. This further 
confirms the great importance of chemical form in nanotoxicology research. During 
toxicological studies, high concentrations of NPs and ions were tested. These 
concentrations can be compatible with the high local NP concentrations following in 
vivo exposure, due to both their internalization and biopersistence. Furthermore, 
the wide range of concentrations allowed us to obtain dose-response curves and 
toxicity benchmarks (i.e. EC50 values) that can be used to identify sub-lethal doses 
useful for investigate NP toxicity mechanisms. 
IV. Cellular uptake of NPs and their corresponding ions. 
We found that NPs are internalized more easily than relative ions. The exposure of 
the three types of cells to Fe-, Co- and Ni NPs led to a large increase in the 
concentration of the metal constituent of the particles, confirming the ability of NPs 
to enter cells. Such increase was much less pronounced for the corresponding ionic 
forms. The different levels of uptake do not explain differences in their toxicity. 
Indeed, despite the highest toxicity of CoNPs, they are internalized less than NiNPs 
and FeNPs. Under our experimental conditions, it was not possible to establish 
whether the intracellular metal was still in the form of particles or ions or both. In 
addition, cell susceptibility is partially related to internal dose, as shown by the high 
susceptibility of lung epithelial cells (A549) and the low sensitivity of hepatocytes 
(HepG2) which internalize huge and low amount of NPs respectively. Moreover, 
study of the subcellular distribution of the internalized metals would be necessary 
to establish whether their metabolic fate are similar for the metallic NPs considered. 
Overall, the present in vitro research comparing metallic NPs constituted by elements 
with similar physico-chemical properties suggests that the evaluation of NPs toxicity 
should be performed on a case by case basis, being very difficult to predict the metallic 
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NP toxicological properties on the basis of their chemical affinity. Our results represent 
the basis for future investigations concerning the assessment of toxicity of metal-based 
nanoparticles. This study rises some concerns related to the development of new 
nanotechnologies and their impact on human health and the environment. Among 
several chemical elements with similar physico-chemical properties, as 
ferromagnetism of Iron Triad, it could be useful to select the most physiological 
elements for a well-defined biological target. This allows to take advantage from 
nanotechnology permitting the biological systems to manage it safely. 
 
